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Abstract
Cervical cancer is the fourth most common cancer and fourth most common cause of
cancer-related death in women in the world. Current guidelines for cervical cancer screening
recommend a Pap and/or human papillomavirus test and a follow-up colposcopy if particular
abnormalities are discovered. In many patients, colposcopies cause significant levels of anxiety,
adversely impacting patients’ pain tolerance and adherence to follow-up. Previous studies have
shown mixed results on whether video colposcopy decreases this anxiety. Moreover, these
effects have not been assessed in low-income communities who are disproportionally affected by
cervical cancer. In this study, we will conduct a single blind randomized controlled trial to
determine whether video colposcopy decreases anxiety associated with colposcopy in lowincome patients. This study may help demonstrate the effectiveness of video educational
interventions in reducing anxiety, potentially establishing video colposcopy as a useful addition
to standard colposcopy practice in this patient population.
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Chapter 1: Introduction
1.1 BACKGROUND
Cervical cancer is a slowly developing cancer that is most commonly caused by
persistent infections with the human papillomavirus (HPV) and is largely preventable with
the HPV vaccine. Currently, it is both the fourth most common cancer and the fourth most
common cause of cancer-related death in women across the globe with a current estimated
incidence rate of 13.1 per 100,000 and a prevalence of about 1,939,000.1-4 In 2015, this cost
the United States an estimated $3.3 billion due to direct healthcare costs and lost productivity
costs from missed work or early death.5
Since the 1950’s, the incidence of cervical cancer and its associated mortality has
significantly decreased in the United States. For 2020, the American Cancer Society
estimates that there will be 13, 800 new cases and an estimated 4,290 deaths due to cervical
cancer.6 This decrease in disease burden is largely due to the success of early detection and
screening programs with HPV testing and the Pap test which can identify precancerous
lesions called cervical intra-epithelial neoplasia (CIN) before it progresses to invasive
cervical cancer.7 Abnormal findings are often followed up with colposcopy where the cervix
is visualized. During the procedure, cervical biopsies, endocervical curettage, or treatment
may also occur if warranted. In the last few decades, this downward trend has stagnated
indicating the need for improvements in rates of screening, in the screening test itself, and in
subsequent evaluation and management of abnormal screening results.6 One aspect requiring
improvement is the significant level of anxiety women experience during all stages of the
cervical cancer screening process, and especially during colposcopy. 8-11 As this anxiety often
leads to several adverse consequences including decreased pain tolerance and subsequently
1

suboptimal adherence to critical follow-up care, further research and development into
effective interventions to decrease anxiety is warranted to improve these health outcomes.1215

In previous studies, it has been shown that the anxiety associated with colposcopy is
due to several factors. Some of the factors include inadequate understanding of cervical
cancer screening, fear of pain or discomfort during the procedure, worries about sexual
dysfunction, and fear of potentially having cancer.9-11,13,16 One study found that some women
thought that coming in for a Pap smear meant that their medical provider thought they had
cancer.17 Other studies have found that women thought that cervical cancer was either
incurable or unpreventable.17,18 With these beliefs about cervical cancer screening in mind, it
is not surprising that in 2003 the National Assessment of Adult Literacy found that only an
estimated 12% of Americans had proficient health literacy with the majority of Americans
having intermediate health literacy with basic health information and services.19 This is
especially concerning as past research has demonstrated that patients with poor health
literacy experience higher anxiety and distress levels.20,21 Thus, the data strongly suggests
that providing more information about colposcopy and the cervical cancer screening process,
and using tools that increase patient engagement could potentially reduce anxiety levels in
these patients.
As such, several studies in the past have attempted to decrease this anxiety using
educational and information sharing interventions. These interventions include information
leaflets, informational videos, pre-colposcopy counselling, and individually targeted
information.8,22-28 Of the studies that looked at the utility of providing informational leaflets
before colposcopy, one smaller study found that providing women with a simple booklet of
2

information reduced anxiety while other larger studies found that their informational leaflet
did not provide any anxiety relief.24,25,28 Inconsistent results have been similarly reported in
studies looking at informational videos prior to colposcopy: one study showed a significant
decrease in patient anxiety while two others showed no significant decrease in patient anxiety
levels.8,22,29 Providing pre-colposcopy counselling or individually targeted information over
the phone and in the mail found negligible effects on reducing anxiety levels as well.23,26,27,30
Ultimately, a 2011 Cochrane review of six randomized controlled trials conducted by Galaal
et al., concluded that of these interventions, only watching an informational video in addition
to an information leaflet showed any significant effect on decreasing anxiety levels in women
undergoing colposcopies.31
Alternative strategies for decreasing patient anxiety include the use of music and
mind-body interventions. It is hypothesized that these tools may be effective not as a way to
provide additional knowledge, but either as a means to distract or calm those undergoing
colposcopy. One study conducted in Chinese patients found that the use of slow rhythm
music significantly decreased patients’ anxiety levels as measured through the Spielberger
State Trait Anxiety Inventory (STAI).32 Similar results are reported in another study
conducted among adolescents that found that music videos decreased patient’s body
movements indicative of pain or distress during the colposcopic examination.33 However,
recently there have been several studies reporting the opposite result.34-37 A systematic
review and meta-analysis of five randomized controlled trials on the effect of music therapy
by Abdelhakim et al. concluded that music had no significant effect on decreasing anxiety
levels in patients presenting for colposcopy.38 However, it should be noted that none of these
studies utilized the same types of music during the colposcopic exam, possibly explaining the
3

heterogeneity of results.32,34-37 Mind body interventions like guided imagery have also found
no effect on reducing patient’s anxiety levels.34 Thus, current available evidence for the use
of distraction or calming tools during colposcopy indicates that they are at best, minimally
effective in reducing patient anxiety levels.
The use of video colposcopy as a tool to decrease patient anxiety shows some
potential. Thus far, only a few experimental studies have investigated its effectiveness with
variable results. One study conducted by Walsh et al. found that the use of video colposcopy
in consecutive colposcopies significantly decreased self-reported anxiety levels during the
colposcopic examination in a group of patients in Ireland.14 Another study found the same
result but only in a subset of patients who scan for threats and seek out information in
response to psychological stress.39 Two other studies have found results inconsistent with
these findings. The study conducted by Rickert et al., who studied adolescents, found that
video colposcopy did not result in significant STAI score differences between the video
colposcopy group and the control group.33 Similarly and more recently, in a large
randomized controlled trial, Hilal et al. found that video colposcopy had no significant effect
on reducing anxiety levels in German women presenting for first time colposcopy measured
using the STAI before and after the colposcopic exam.40 This heterogeneity of results might
be explained by the different patient populations studied in these trials as well as
methodological differences in the study designs. Demographic characteristics in several of
these studies did not include race, ethnicity, or socioeconomic status and so comprehensive
comparisons between the studies are unable to be reliably drawn and extrapolated into other
patient populations. In light of these variable results, incomplete demographic data, and
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protocol differences, further investigation is needed to determine if similar effects will be
seen with the use of video colposcopy across different patient populations.
As the majority of these studies were conducted in Europe, whose patient populations
are considerably different from the U.S., the utility of video colposcopy as a strategy to
decrease anxiety in low-income patients is still unknown. Evidence in the literature suggests
that culture has significant influences on how individuals experience anxiety, suggesting that
patient populations from different cultures may react to video colposcopy differently as an
intervention to reduce anxiety.41,42 Moreover, none of these studies have looked at lowincome populations in the U.S. who are predominantly racial and ethnic minorities who have
the highest burden of cervical precancer and cancer in America.43-45 This highlights the need
for more research into these vulnerable groups. According to the article by Singh et al, from
2009-2013, women in the lowest socioeconomic status (SES) bracket had a 76% higher
cervical cancer mortality rate than women from the highest SES bracket.43 Health disparities
by race and ethnicity also continue to persist in cervical cancer statistics in the U.S. As of
2016, incidence rates and mortality rates from cervical cancer have been found to be higher
in black women and Hispanic women compared to white women at 8.7 and 9.8 versus 7.5 per
100,000 and 3.1 and 2.7 versus 2.1 per 100,000, respectively.45,46 Poor health literacy also
afflict these low-income and minority populations illustrating the urgent need to identify
interventions to target their lack of knowledge and in doing so, decrease their anxiety upon
presentation for colposcopy.47-49 Fortunately, previous research has demonstrated that the use
of culturally sensitive and targeted video technology can help increase patient knowledge and
overcome barriers posed by limited education .8,50-54 Based on this data, further investigation
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into video colposcopy is warranted to evaluate whether it is a useful intervention to decrease
anxiety in these low-income patients undergoing first time colposcopy.
1.2 STATEMENT OF THE PROBLEM
A few randomized controlled trials to date have examined video colposcopy as a
potential tool to decrease anxiety in patients presenting for first-time colposcopy. Previous
studies have produced mixed results on its efficacy with some studies demonstrating a
benefit with video colposcopy and others demonstrating none. However, these current studies
are limited in the interpretation of their results as several of them feature design elements that
introduce sources of bias and are limited in generalizability. These design elements range
from using a poor method to randomize patients to failing to account for certain confounders.
Moreover, each of the four published randomized controlled trials studied a different
population of interest and failed to report important sociodemographic information on their
sample populations.14,33,39,40 Given the limited external validity of these studies, the utility of
video colposcopy to decrease anxiety remains unknown in low-income and minority patients
who are disproportionately affected by cervical cancer in the United States. The proposed
study will be a randomized controlled trial to determine the efficacy of video colposcopy in
reducing anxiety in a population who is grossly understudied and has the potential to benefit
greatly from the results.
1.3 GOAL AND OBJECTIVES
The goal of this proposal is to determine whether video colposcopy is a useful tool to
effectively decrease anxiety levels in low-income women undergoing colposcopy for the first
time. The proposed study will evaluate whether the use of video colposcopy as an interactive
information sharing tool during the colposcopic exam will lead to a significant reduction in
6

anxiety levels compared to standard non-video colposcopy and improve adherence to followup in these patients. The primary outcome will be the mean reduction in anxiety. Patient
adherence to follow-up, patient satisfaction, patient knowledge of colposcopy and cervical
dysplasia, and patient pain during the colposcopic exam will also be measured to determine if
video colposcopy improves these secondary outcomes. This study ultimately hopes to inform
colposcopy practice on a way to decrease anxiety in first time colposcopy patients.
1.4 HYPOTHESIS
We hypothesize that low-income patients presenting for first time colposcopy
randomized to video colposcopy will have a different mean change from baseline in the
Spielberger State Trait Anxiety Inventory (STAI) when compared to those patients
undergoing traditional non-video colposcopy.
1.5 DEFINITIONS
Video Colposcopy: Video colposcopy utilizes a video colposcope to enable both the
clinician and the patient to view in real time, the cervical examination that is being performed
on a television monitor.
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Chapter 2: Review of Literature
2.1 INTRODUCTION
We conducted a comprehensive search from the following databases between June
2019 and May 2020: PubMed, Ovid MEDLINE, EMBASE, and PsycINFO, Cochrane
Library, Scopus, and Sociological Abstracts. The following terms or a combination of these
terms were used to search for relevant literature: colposcopy, video colposcopy, colposcope,
anxiety, State Trait Anxiety Inventory, fear, pain, cervical cancer, cervical cancer guidelines,
anxiety across cultures, adherence, patient satisfaction, patient knowledge and health
literacy. Key terms used to search for protocol and methodology specific determinations
included: confounders, side effects, and safety. Articles in the English language or English
translations were evaluated for theoretical soundness, strength of design, and significance of
data. Pertinent articles were included and further analyzed in this review.
2.2 CERVICAL CANCER, SCREENING, AND ANXIETY
Cervical cancer occurs when cells in the cervix undergo abnormal changes most
commonly caused by oncogenic strains of the human papillomavirus (HPV). This process
usually occurs over several years and therefore most women who are diagnosed with cervical
cancer are usually between the ages of 44 and 68.1 Because this cancer develops over a
relatively long period of time, it is one of the very few cancers that is largely preventable
with the HPV vaccine and cervical cancer screening programs.
The cervical cancer screening process begins at age 21 for women in the U.S. The
U.S. Preventative Task Force currently recommends that women aged 21-29 receive a Pap
test every 3 years and women aged 30-65 screen with a Pap test alone every 3 years, highrisk HPV testing alone every 5 years, or cotesting every 5 years.2 Following a Pap test, if
12

certain abnormalities are found, women are subsequently referred for a colposcopy, a
standard diagnostic procedure that uses a stereoscopic binocular microscope to visualize the
cervix and obtain biopsies of any areas suspicious for neoplasia. In the literature, it has been
well documented that women experience significant levels of anxiety both before and during
this procedure.3-7 As this anxiety with colposcopy has been associated with decreased pain
tolerance, psychosocial and psychosexual dysfunction, and decreased adherence to follow up,
various interventions have been developed to help provide anxiety relief in these patients.7-12
2.3 REVIEW OF PREVIOUS INTERVENTIONS TO REDUCE ANXIETY
Several strategies have been investigated to help decrease anxiety in women attending
their first colposcopy with educational and distraction or calming interventions being the
most studied. The following detailed review consists of several trials that have tested the
utility and efficacy of these interventions.
Informational Leaflets and Booklets
One strategy used to decrease anxiety has been to provide informational leaflets or
booklets to patients prior to colposcopy. Three studies to date have investigated their use
with varied results. One small study (n=64) conducted by Marteau et al., showed that sending
a simple informational booklet in the mail prior to colposcopy that contained procedural
information, behavioral instructions, and outcome information significantly decreased
patients’ anxiety.13 In the study, there were 4 different groups. Group 1 underwent routine
care, Group 2 was sent a simple informational booklet, Group 3 was sent a complex
informational booklet, and Group 4 was sent both booklets. Anxiety was measured using the
state scale of the Spielberger State Trait Anxiety Inventory (STAI), a validated scale of
anxiety that utilizes a 20-item questionnaire and a 4-point Likert scale. 14 Scores range from
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20-80 with higher scores indicating higher anxiety. Scores were compared at two time points:
upon receipt of the colposcopy appointment and right before colposcopy. The first STAI
scores were taken after receipt of any booklets in the mail.
The STAI scores of the groups were as follows upon receipt of appointment: Group
1=46.2, Group 2= 43.9, Group 3= 46.8, and Group 4=38.3, p <.05. The following STAI
scores were those obtained at the appointment: Group 1= 50.7, Group 2= 44.8, Group
3=49.1, and Group 4=42.1, p <.025. At both time points, Group 2 and Group 4 had
significantly different mean STAI scores compared to Groups 1 and 3. The authors thus
concluded that those groups that received the simple informational booklet were less anxious
after receipt of the simple booklet compared to those groups who did not receive it.
However, while this study demonstrates some significant anxiety reduction with an
informational booklet, there are some limitations to this study. One limitation is the absence
of confirmation that the women who were sent the informational booklets in the mail actually
read them. Thus, caution must be taken to attribute the differences in anxiety to the simple
informational booklet alone as it is possible the women also relied on other sources of
information. Another limitation is the small number of participants in each group (Group 1:
n=13, Group 2: n=21, Group 3: n=15, and Group 4: n=15) as well as the absence of sample
size calculations. These aspects of the study call into question whether this study was
powered correctly to detect a clinically significant effect size.
Two larger randomized controlled trials evaluated the provision of informational
leaflets or handouts prior to colposcopy and found results contrary to those found by Marteau
et al.15,16 Tomaino-Brunner et al. (n=113) conducted a quasi- randomized controlled trial
assessing the effect of an educational intervention on knowledge and anxiety in patients
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scheduled for a colposcopy. This study found no significant difference in STAI scores
between those who received an educational handout in the mail one week prior to the
colposcopy and those who did not.15 STAI scores prior to the colposcopy in the intervention
group and the control group were 47.9 12.8 and 50.813.3, respectively. The difference in
STAI scores was not found to be significant (p-values were reported as nonsignificant but no
specific values were reported). However, it should be noted that the authors powered their
study based only on knowledge of colposcopy and not on STAI scores. Based on a previous
study the investigators had conducted, they found that only 30% of women knew what a
colposcopy was and used this percentage as their estimated effect size in their sample size
calculations.15 One methodological weakness of this study includes the method of allocation
which used a randomization scheme based on the week of scheduled appointment rather than
a truly random allocation, increasing the risk of selection bias. The lack of a pre- and posttest design also makes it hard to determine if the handout was truly the variable that produced
the end results. The results of Howells et al. support those found by Tomaino-Brunner et al.
In a prospective randomized controlled trial (n=200), they found that the provision of
informational leaflets prior to colposcopy did not produce a statistically significant difference
in STAI scores between the intervention and control groups, either before colposcopy or at
the 6-month follow-up visit.16
It should also be noted that the studies conducted by Marteau et al. and Howells et al.
are limited in terms of their external validity as neither study listed demographic information
concerning race and ethnicity or SES. Thus, the generalizability of their results to other
patient populations is unknown at this time. Overall, the results of these studies are
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inconsistent and inconclusive regarding the efficacy of these interventions in reducing
anxiety.
Pre-colposcopy Informational or Counseling Sessions
Pre-colposcopy information sessions with counselling have been evaluated in three
randomized controlled trials but have shown negative results. In a quasi- randomized
controlled trial conducted by Sarkar et al. (n=59), women who received an even hospital
number received counseling by the clinic nurses before filling out a questionnaire about
anxiety and depression.17 Women who received an odd number filled out the questionnaire
before they received counselling. Anxiety was measured using the STAI and no significant
differences between the mean STAI scores were seen between groups. In two other studies
(n= 147-220), informational leaflets and video information were provided to both the
intervention group and the control group prior to colposcopy. 18,19 In addition to these
resources, an additional discussion with an experienced colposcopy nurse was provided in
the study by Chan et al. and pre-colposcopy group sessions with a colposcopy nurse was
provided in the study by Byrom et al. to the intervention group. No significant differences in
mean STAI scores between groups were detected in either of the studies.18,19 The mean STAI
score in the study by Chan et al. prior to the colposcopic examination was 45.2111.88 in the
intervention group and 45.819.89 in the control group.18 In the Byrom et al. study, the mean
pre-colposcopy STAI score was 46.36 11.98 in the intervention group and 45.94  13.99 in
the control group. However, the study conducted by Byrom et al. did not recruit enough
participants to achieve their sample size to power the study. Thus, the study may not have
been large enough to detect the effect size. Similar to previously mentioned studies, all three
studies are limited in generalizability of their results as the study conducted by Chan et al.
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only recruited Chinese patients and the studies conducted by Sarkar and Byrom et al. did not
report race and ethnicity or SES data.
Targeted Information
As anxiety can be quite individualized, one randomized controlled trial published in
2011 by De Bie et al., looked at whether targeted information through the mail or telephone
would provide any anxiety relief to these women. 20 Women who were randomized to the
intervention group received a phone call that included topics about the Pap result, precancer
versus cancer, the colposcopic procedure, treatment, HPV, HPV vaccination, and fertility.
They also received a document that included information about the screening program,
abnormal smear results, and steps after an abnormal smear result. The control group received
a 2-page informational leaflet that included information about colposcopy and treatment.
Anxiety was measure using the STAI on arrival to the colposcopy clinic. The median STAI
score for the intervention group was 48.0 (42.0-56.0) and the median STAI score for the
control group was 50.0 (40.0-59.0), p=0.92. Thus, no significant difference was found
between the median scores between the intervention group and the control group with
targeted information over the phone and in the mail.
Informational Video
Studies conducted by Freeman et al., Ketalaars et al., and Wouters et al., have
assessed the utility of an informational video as a medium to decrease anxiety. The earliest of
these studies (n=93) by Freeman et al. in 2001, utilized a 7-minute clinic-specific video that
included information about abnormal Pap smears, the consultation, and possible treatments.4
This videotape and a standard explanatory leaflet were sent to women in the intervention
group prior to their see and treat colposcopy appointment and only the explanatory leaflet
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was sent to the women in the control group. Anxiety was measured using the STAI at the
woman’s first attendance to the clinic. The mean STAI score of those who received the video
and the leaflet was 43.2 12.09 while the mean STAI score of those who only received the
leaflet was 54.7  12.58, P=.00004. The authors therefore concluded that the video
significantly reduced their patients’ anxiety. The videotape cost £1.50 for each woman in the
video group making it more likely that these women did indeed watch the video compared to
if the videotape was free. This is because there is a monetary loss if the women choose not to
watch the video. However, there was no formal verification that the women who received the
videotape actually watched the video. Thus, these results must be interpreted in the context of
this limitation.
Two recent larger randomized controlled trials provide contradictory results to those
found by this study. In 2017, Ketalaars et al. (n=136) examined the efficacy of an 11-minute
video prior to colposcopy in decreasing anxiety. The content of the video was very similar to
the one used by Freeman et al., and included hospital and clinic specific images as well as
explanations of abnormal smears, the consultation, and possible treatments.21 Women
randomized to the intervention group received a link and password through the internet for
the online video and the standard informational brochure through the mail and women
randomized to the control group only received the standard informational brochure. The
primary outcome was difference in anxiety between the groups as measured by the STAI and
the Hospital Anxiety and Depression Scale (HADS). The mean STAI score after the
invention in the video group was 44.3 10.7 while the mean STAI score in the control group
was 44.9 11.0, p= .752. The mean HADS anxiety score after the intervention in the video
group was 6.24.4 while the mean HADS score in the control group was 6.74.6, p=.491.
18

Neither of these measures was found to be statistically different between the two groups and
the authors concluded that video information did not reduce anxiety levels in women referred
for their first-time colposcopy.
The results of the previous study are supported by Wouters et al. In 2019, Wouters et
al. (n=122) studied the effect of a hospital-independent animation video on consultation time,
anxiety and satisfaction.22 The methods of this study were similar to the prior studies. The
animation video included information on different cytology results, the colposcopy
procedure, possible treatments, possible side effects, and follow-up procedures. Women in
the intervention group received this video and standard written and oral information on
colposcopy and the control group just received the written and oral information prior to
colposcopy. Anxiety was measured via the STAI and the HADS. The pre-colposcopy mean
STAI score in the animation video group was 46.8 10.4 and was 44.210.6 in the control
group, p=0.16. The pre-colposcopy mean HADS anxiety score in the animation video group
was 4.0 (2.5-6.0) and 4.0 (2.8-5.3) in the control group, p=0.58. Thus, no significant
difference in mean STAI or HADS was observed between the two groups.
In reviewing these three studies, it should be noted that all three studies are either
limited or uncertain in terms of their external validity. Freeman et al. conducted their study in
London, England, and only state that there are no differences between the two groups but
failed to display any demographic information. Thus, it is unknown whether the results they
see in their study can be applied to other populations of women. The same problem limits the
generalizability of the studies done in the Netherlands by Ketalaars et al. and Wouters et al.
as they both fail to report the race and ethnicity or SES of their participants. It could be
argued then that the difference in results is due to different patient populations. Thus, with
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the information that is currently available, no definitive conclusions on video interventions
can be made on reducing anxiety in the population of women we will be studying, as the
populations studied thus far are not representative of those in the U.S.
Music
In addition to educational interventions, a few other distraction or calming tools have
been evaluated to provide anxiety relief. Several studies have looked at music.
One of the first studies looking at music was conducted in 1994 by Rickert et al. who
conducted two consecutively occurring studies that examined the effect of music videos and
video colposcopy on decreasing anxiety in adolescents presenting for colposcopy.23 The
results of the video colposcopy study will be discussed later in the section titled “Overview
of Video Colposcopy.” In the study assessing music videos, 30 patients aged 13-20 were
randomized to either the music video group or to the control group. The music video was
selected prior to the exam and each participant watched the same music video. Several
measures were used to assess anxiety including behaviors indicative of distress, the STAI,
and heart rate. Some of the behaviors indicative of distress included the clinician giving
reassuring comments to the patient or the patient commenting on pain. These behaviors were
then coded into a list and an observer recorded the frequencies of these behaviors throughout
the exam. They found that those participants in the music video group demonstrated
significantly fewer behaviors and body movements indicative of pain and discomfort
(P<.003), less reassurance from the provider (P<.05) and required fewer explanations from
the clinician (P<0.007). Other behaviors, STAI and heart rate were found to be nonsignificant. Thus, the authors concluded that the music video had a positive effect on anxiety
and distress. It should be noted that as this study was performed in adolescents who are no
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longer recommended for routine cervical cancer screening, the generalizability of these
results is fairly limited. Additionally, the measure that was found to be significant in this
study (coded behaviors indicative of distress) is not well-validated, making the results less
reliable.
A study conducted by Chan et al. in 2003 examined the effects of instrumental music
to decrease anxiety in a group of 220 Chinese women and provide further support for the
results found by Rickert et al.24 Patients filled out the STAI questionnaire (translated into
Chinese) prior to colposcopy and again after the procedure. Slow rhythm instrumental music
was played on speakers to those women randomized to the music group. The colposcopic
exam was performed by a gynecological oncologist or a gynecologist with an interest in
colposcopy, but no standard format of counseling was used among these clinicians. Using
mean STAI score as one of their primary outcomes, music was found to significantly reduce
anxiety in women presenting for first time colposcopy. Women in the music group had a
mean post-colposcopy STAI of 39.36 (95% CI 37.33-41.39) compared to women in the
control group whose mean post-colposcopy STAI was 44.16 (95% CI 41.82-46.49).24 A
Cochrane review by Galaal et al. examining six studies on interventions for reducing anxiety
in women undergoing colposcopy found that this reasonable large study had a low risk of
bias based on its random sequence generation and concealment of allocation.25 It should be
noted however that this study was only conducted among Chinese women, utilized multiple
clinicians to perform the colposcopy, and did not examine whether the music affected
physician behavior and performance, in effect limiting the generalizability of the study and
introducing unadjusted confounders to this study.
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In contrast to the results of those found by Rickert et al. and Chan et al., many studies
have found that music does not significantly decrease anxiety in women presenting for
colposcopy. One study conducted by Danhauer et al. in 2007 examined the effect of music
and guided imagery on decreasing anxiety in a reduced-fee colposcopy clinic.26 The aim of
their study was to determine if mind-body interventions could decrease anxiety and perceived
pain. 170 women were randomized to three groups: a music group, a guided imagery group,
or a usual care group. The women that were randomized to the music intervention were
provided several different music options on a compact disc (CD) including classical, harp,
general instrumental, or nature sounds through headphones. Women in the guided imagery
intervention were provided a CD with an audio recording titled A Meditation to Help you Be
Relaxed and Awake During Medical Procedures by Naparstek. Using mean STAI as their
primary outcome, they found no significant difference in either the music intervention group
or the guided imagery group compared to the usual care group.26 Interpretation of these
results should take note that 31.9% of the women recruited reported that they have had a
prior colposcopy before, possibly confounding the results. Like the study conducted by Chan
et al., this study also had multiple clinicians performing the colposcopy which again may bias
the results.
A single-blind prospective randomized controlled superiority trial by Mak et al. in
2017 also examined the effect of music in gynecological procedures on pain, anxiety, and
patient satisfaction. Patients were stratified by hysteroscopy and colposcopy. Those in the
music intervention group were provided several different music options including pop,
classical, and spa music which was played on an iPod with speakers during the procedure.27
Their primary outcome was pain during the procedure measured using the Visual Analog
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Scale (VAS) from 0-100 mm and one of their secondary outcomes was anxiety measured
using the STAI before and after the procedure. They found that there was no significant
difference in pain or anxiety between the music group and the control group. 27 One
particular and unique strength of this study was that it was single blinded. Participants in the
study were only told that they would be participating in a study about pain relief and not the
role of music, reducing response bias. However, while this study showed no significant
difference with music in lowering anxiety, a number of limitations must be highlighted. This
includes the various options of music provided to the patients, the various providers who
performed the colposcopy, and the lack of documentation of waiting time and duration of the
procedure which all may act as confounders in this study, limiting the interpretations of these
results.
Two other additional studies mirror the results found by Danhauer et al. and Mak et
al. These studies conducted by Chantawong et al. in 2017 and Hilal et al. in 2018 used only
one type of music to assess whether music could decrease anxiety.28,29 Chantawong et al.
played relaxing modern western style instrumental music in a stereo headset during loop
electrosurgical excision procedures in 150 patients while Hilal et al. played Mozart’s
symphony No. 40 during colposcopy in 205 patients. The primary outcome examined in the
study by Chantawong et al. was procedural pain and baseline pain scores with anxiety as a
secondary outcome measured through the VAS. The primary outcome of the study conducted
by Hilal et al. was reduction in mean STAI. Like previous studies, both studies did not find
significant differences between the music and control groups.28,29
Additionally, a recent systematic review and meta-analysis by Abdelhakim et al. of
these five randomized controlled trials ultimately determined that no effect was ultimately
23

seen with music therapy in reducing anxiety levels compared with the control group.30 When
analyzing the data, they found that there was a high heterogeneity of results. However, once
the study conducted by Chan et al., was removed, this completely resolved. Thus, it seems
that the results from the Chan et al. study, as mentioned previously, may be limited to the
primarily Chinese population that was studied.
2.4 OVERVIEW OF VIDEO COLPOSCOPY
Previous Studies Assessing Video Colposcopy to Decrease Anxiety
To date, the specific use of video colposcopy as a tool to decrease anxiety has been
studied in a few populations of interest. The first reported study in the literature assessing
video colposcopy to decrease anxiety was in adolescents in 1994 in the same article
mentioned previously assessing the use of music videos to decrease anxiety in adolescents.23
This small study (n=27) recruited female adolescents aged 13-20 years and randomized them
to either the video colposcopy group or the control group.23 Multiple measures of anxiety
were measured including a list of behaviors indicative of distress, STAI, and heart rate. The
list of behaviors indicative of distress included items like reassurance from the clinician or
comments about pain. 23 These behaviors were coded and the frequency of these behaviors
was then documented during the procedure. Study participants randomized to the video
colposcopy group were told they could watch the procedure on the television monitor but
were not forced to do so. The only significant difference demonstrated amongst participants
randomized to video colposcopy versus traditional colposcopy was that subjects in the
control group provided more responses to the provider inquiring about their pain or
discomfort.23 All other measures were nonsignificant. However, several elements of the study
limit the interpretation of the results. First, the authors fail to elaborate on the details of how
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each patient was randomized to each group. As the study only reported that patients were
randomized but not how, it is unclear if selection bias was actually eliminated. Similarly,
there is no mention of whether there was any concealment of allocation, introducing another
source of potential bias. The sample size of the study is also small (n=27), reducing the
statistical power of the study. Furthermore, there is no mention of sample size calculations
making it difficult to assess whether the study recruited enough participants to detect a
difference in effect between the two groups. In terms of measured outcomes, the use of the
list of coded behaviors is unvalidated, making these results somewhat unreliable. Finally,
while the study reports that there were no significant baseline differences in their patients or
in the other measures of anxiety like STAI and heart rate, they failed to display this data in
their paper and did not speak about possible confounders and whether they were adjusted for
in their analysis. Thus, while this study produced a negative result, the reported results must
be interpreted in the context of these various limitations.
In 2004, one relatively small quasi-randomized controlled study (n=81), conducted in
Ireland demonstrated that the use of video colposcopy in consecutive colposcopies
significantly reduced anxiety in patients compared to traditional colposcopy.10 Patients
presenting for first time colposcopy were randomly assigned to the video colposcopy or
control group in strict alternating rotation and the same clinician and nurse were present at
each procedure. Patients were then divided into two groups based on their diagnosis on the
first visit to determine the effectiveness of the video colposcopy intervention in patients with
two different diagnostic conditions. One group included participants who had cervical
intraepithelial neoplasia (CIN) I, CIN II, or CIN III and needed laser treatment. The other
group included patients who had no abnormalities detected. Those in the former group (the
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laser group) required two more visits- one for the laser treatment and another four months
after receiving the laser treatment. Those who had no abnormalities detected on the first visit
followed up in one year. The primary outcome was reduction in anxiety as measured by the
difference in first and final STAI. In the laser group, STAI was found to be significantly
reduced from the first to the final visit compared to those in the control group. Those in the
laser video colposcopy group had an initial STAI of 51.82 (SD 14.22) and a final STAI of
31.86 (SD 5.56), compared to those in the laser control group who had an initial STAI of
51.62 (SD 12.56) and a final STAI of 40.29 (SD 7.06). The results of those who had no
abnormalities detected on the first visit also reflect this result with those in the video
colposcopy group having a first visit STAI of 49.05 (SD 11.03) and a final STAI of 34.70
(SD 6.23) compared to those in the control group who had an initial STAI of 52.33 (SD
13.46) and a final STAI of 44.78 (SD 9.89). While this study shows potential for the efficacy
of video colposcopy to reduce anxiety, the study fails to provide certain details about the
patients’ demographic information like race/ethnicity, socioeconomic status, or pre-existing
comorbidities or mental health issues. These missing patient characteristics limit the
interpretation of the results as it is unsure whether any of these patient characteristics may
operate as confounders. The poor method of randomization and concealment also increases
the risk of selection bias as their randomization technique is not truly random and it is based
on an order that can be predicted. Nevertheless, despite these methodological weaknesses this
early study demonstrated that video colposcopy may be a useful tool in decreasing anxiety in
patients presenting for colposcopy.
Another study by Kola et al. conducted in 2012 provides support for these results in a
specific subset of patients who were identified as “high monitors”, meaning those who prefer
26

to have more information in stressful situations.31 In this study, the investigators assessed
whether tailoring information to an individual’s coping style would decrease distress in
patients presenting for first time colposcopy. 117 patients were recruited for the study and
divided into low or high monitors. This classification was based on their scores from the
Miller Behavioral Style scale which asks patients what they would do in hypothetical
threatening situations. They were then randomized to three different groups: high
information, low information, and control. Those randomized to the high information group
watched their examination on a monitor with a video colposcope. Those randomized to the
low information group watched and listened to a DVD with nature scenes and soothing
instrumental music using a head-mounted display with headphones. Those in the control
group had usual care. Both physiological measures (systolic blood pressure, diastolic blood
pressure, and heart rate) and self-reported measures of anxiety using the STAI were recorded
before and after the colposcopic procedure. Observational measures of distress including
moaning and groaning were also recorded approximately five minutes after the exam had
begun. All colposcopies were done by one nurse colposcopist. They found that those patients
who were high monitors experienced a reduction in systolic blood pressure from precolposcopy levels in both the high and low information groups. Low monitors showed an
increase in systolic blood pressure during the exam compared to pre-colposcopy levels when
in the high information group and a decrease in systolic blood pressure in the low
information and control groups. Self-reported measures of anxiety failed to show any group
differences while both high and low monitors exhibited fewer overt signs of distress in the
low-information group. One strength of this study compared to the others is the use of
objective measures to measure anxiety. However, they did not exclude patients who used
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medications that affect blood pressure and heart rate. Thus, the interpretations of the results
may be biased. Future studies will need to incorporate this exclusion criteria to provide more
compelling data.
Recently, a larger prospective randomized multicenter controlled trial (n=225)
conducted by Hilal et al. in Germany, demonstrated no significant reduction of anxiety with
the use of video colposcopy.32 Their primary outcome was the mean reduction in anxiety
scores and was not found to be significantly different between those who had a video
colposcopy and those who had a traditional non-video colposcopy (-10.3 11.3 SD in 111
women in the video colposcopy group and -10.3  11.0 SD in 105 women in the traditional
colposcopy). This study demonstrated many aspects of a well-designed RCT. The study was
a multicenter study conducted in both a doctor’s office setting and hospital setting expanding
the generalizability of the study. Participants were given an informational leaflet to
standardize medical knowledge about cervical cancer, HPV, and colposcopy; and the
colposcopic exam was standardized decreasing possible sources of confounding. The method
of concealment of allocation was also appropriate as they used a staff member not involved
in the study to place the allocation slips into consecutively numbered opaque envelopes.
They also calculated their sample size appropriately based on data from the study conducted
by Chan et al. and recruited enough patients to achieve this calculated sample size.24
However, there are certain elements of their protocol that may help explain the
negative result of their study. First, while they did use a computerized randomization tool to
randomize patients, they utilized block randomization with block size four making it possible
for the staff member who performed this random allocation to predict the allocation of some
participants, introducing a possible source of bias. The baseline characteristics of the
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participants also showed some differences that may explain why video colposcopy did not
reduce anxiety in these patients. In the video colposcopy group, there were more women who
had concomitant disease (48 (43.2%) vs 38 (36.5%)) and more colposcopic findings
suspicious for invasion (5 (4.5%) vs 0). Women who have concomitant diseases may already
have a high burden of anxiety from preoccupation with their other disease making video
colposcopy less effective. Similarly, women who are told that their colposcopy found lesions
suspicious for invasion may not find video colposcopy helpful in reducing anxiety due to the
heightened concern for cancer. Moreover, the majority of women in the study had major
changes on colposcopic exam (48.6% in the video colposcopy group and 53.8% of the
control group). This may explain why video colposcopy did not decrease anxiety as the
graphic nature of some of these lesions may have served to increase anxiety. Thus, this study
may have benefited from a multiple linear regression analysis with concomitant disease and
colposcopic findings as independent variables.
In terms of analysis, the study reports that analysis was by intention to treat but nine
protocol violations occurred and these patients were not included in the final analysis; three
were from the video colposcopy group and six were from the control group. Since not all
randomized patients were analyzed, the data was not actually analyzed by the intention to
treat principle. As this exclusion compromises the original randomization, this may be a
source of bias as it may have created important prognostic differences between the groups.
For example, if the six patients from the control group who were not included in the final
analysis had more anxiety regarding colposcopy, this exclusion would skew the results so
that the effect of video colposcopy to reduce anxiety was underestimated. The study also
conducted a subgroup analysis looking at patients who were the most and least anxious. They
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found that video colposcopy also did not reduce anxiety in either of these groups. However,
this may be misleading as these subgroups were both small (n=55 for the most anxious
patients vs n= 56 for the least anxious patients). Therefore, there may not have been enough
people in each group to detect an effect size if there was one. Lastly, the generalizability of
this study is limited as this study was conducted in Germany and important patient
characteristics like race, ethnicity, and SES were not reported. It is therefore unclear whether
these same effects would be seen in other patient populations.
Thus, so far, the existing data remains both limited and mixed on the utility of video
colposcopy in reducing anxiety in patients who present for first time colposcopy.
Additional Demonstrated Benefits of Video Colposcopy
While research in evaluating the efficacy of video colposcopy in decreasing patient
anxiety levels undergoing colposcopy has not produced a definitive consensus, there have
been many other demonstrated benefits of video colposcopy. One significant outcome is
improved adherence to follow-up care. A review of literature by Eggleston et al. identified
that some of the risk factors for decreased adherence to follow-up care include race and
decreased knowledge of the cervical cancer screening process.7,33 A study looking at video
colposcopy for improving adherence found significantly increased adherence rates from 50%
in patients who underwent a traditional colposcopy to 80% in patients who had a video
colposcopy.34 This is a significant finding as close surveillance and follow-up after a single
colposcopy is indicated even in patients in whom no or low risk abnormalities are identified.
Among women with high grade cervical abnormalities found at time of colposcopy, more
immediate interventions are often indicated but subsequent short interval surveillance follow
up is also needed to ensure a patient has returned to a baseline population-level risk of future
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cervical cancer. Other demonstrated benefits of video colposcopy include improved patient
knowledge as well as improved patient satisfaction although data has been variable with the
latter.22,32,35,36
Side Effects
The same side effects or complications from traditional colposcopy can also result
from video colposcopy. These side effects or complications include: bleeding, cramping or
pain, vaginal discharge, and in rare cases infection. Results from the study conducted by
Hilal et al. indicate that patients experience a negligible level of discomfort and anxiety from
watching the live video during video colposcopy. 32
2.5 REVIEW OF RELEVANT METHODOLOGY
Study Design and Blinding
Currently in the literature, most of the studies assessing video colposcopy have used
an unblinded randomized controlled trial design.10,23,31,32 All of these studies assessing video
colposcopy were unblinded due to the nature of the intervention. One study conducted on the
efficacy of music to decrease pain during gynecological procedures used a single blind
design where the participants were informed that they would be taking part in a study about
pain relief but were not informed about the role of music until afterwards.27 As our
intervention is similar, a single blind study design is justified and will decrease response bias.
Previous studies lack any details about the blinding of outcome assessors and data analysts,
but in order to decrease any potential sources of bias, this protocol is justified and will
provide the most robust evidence to assess the utility of video colposcopy in decreasing
anxiety in first time colposcopy patients.
Randomization Techniques
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Prior studies have used various methods to randomize their patients. One study
randomized every second patient to the treatment group while another study had their
patients select a random assignment slip.10,26 An additional study randomized patients by
using week of scheduled appointment.15 These methods are not truly random as in the first 2
cases, randomization depends on an order and in the third case, is subject to seasonal or
temporal variation. Consequently, these techniques may not represent the best methods to
randomize patients. Another study utilized block randomization (block size 4) with a 1:1
allocation ratio. 32 While this method is more truly random, the staff member who performed
the random allocation may be able to predict the allocation for later patients in the block,
introducing a source of bias. Most other studies utilized a computer-generated random
number series to allocate their patients to treatment or control.16,18,19,21,24,28 As this represents
a truly random method to allocation patients, this randomization technique is the most
appropriate for the proposed study to reduce selection bias.
Primary Outcomes
Most studies conducted on interventions to reduce anxiety in first time colposcopy
patients have utilized the Spielberger State and Trait Anxiety Inventory (STAI) to measure
anxiety.4,13,15,16,18-21,23,24,27,29,31,32 This inventory was originally developed by Spielberger et al.
and is a self-reported measure of anxiety composed of 40 items- 20 items for the assessment
of trait anxiety and 20 items for state anxiety.14 Trait anxiety refers to a more constant state
of anxiety that an individual exhibits whereas state anxiety refers to anxiety that is more
transient and experienced in a specific time and situation. Examples of statements assessing
trait anxiety include: “I am a steady person” and “I worry too much over things that don’t
really matter.” Examples of statements assessing state anxiety include: “I am tense” or “I feel
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calm.” These 20 items on both the state and trait versions of the STAI are rated on a 4-point
Likert scale. Scores range from 20 to 80 with higher scores correlating with increasing
anxiety. It has been suggested that 40 be the cutoff point to detect clinically significant
anxiety.14,37 Cronbach’s alpha scores have been reported to be between 0.86-0.95 for working
adults, college students, high school students, and military recruits.14 The test-retest
reliability for the STAI in high school students and college students was found to be .68-.86
for trait anxiety and.16-.62 for state anxiety.14 The low stability values for state anxiety are
reasonable as it reflects a measure of anxiety in a specific time and situation. One
disadvantage of this inventory is that it is a self-reported measure of anxiety. However, as
various disciplines have utilized this inventory and found it to be a reliable and validated
measure to detect anxiety, this inventory remains one of the gold standards to measure
anxiety.14
Some other studies have also utilized physiological measures as a proxy to measure
anxiety like heart rate, systolic blood pressure, and diastolic measure in order to supplement
self-reported measures of anxiety to obtain more objective data. 23,31 However, while these
measures may be more objective, heart rate and blood pressure can be affected by various
factors including but not limited to medication use, disease processes, or substance use.38
Moreover, these physiological measures are proxies of anxiety and while they show promise,
they have not been well-validated to measure anxiety. Therefore, as STAI has been more
widely validated as a scale to measure anxiety, we will utilize the difference in precolposcopy STAI and post-colposcopy STAI to measure mean reduction in anxiety as our
primary outcome.
Secondary Outcomes
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The secondary outcomes we will measure include adherence to follow-up, patient
satisfaction, patient knowledge of colposcopy and cervical dysplasia, and pain during the
colposcopic procedure.
Prior studies have measured patient adherence to follow-up in various ways. One
study measured patient adherence rates and this was calculated by dividing the total followup visits attended by the total number of appointments made.18 Another study measured
adherence by whether or not the patient came to her follow-up or rescheduled. 34 As we are
more interested into whether the patient comes to the next follow-up visit and not the overall
adherence rate to follow-up appointments, we will use the latter method.
Prior studies assessing patient satisfaction using video colposcopy have used highly
variable methods ranging from using ratings of satisfaction using 3-5 point scales10,26,27 to
utilizing a visual analog scale (VAS).28,29,32 Most of these scales are not well-validated nor
are they specific to colposcopy. The PEACE-q was developed by Pop et al. and is the first
questionnaire developed to assess satisfaction specifically in colposcopy patients. While it
has only been used in one published article and it has not been widely validated yet, it has
been demonstrated to have good psychometric properties with a Cronbach’s alpha of
0.76.22,39 The questionnaire has 8 items which are rated on a 4-point Likert scale. Higher
scores correspond with higher satisfaction with the colposcopy procedure. As this
questionnaire demonstrates an acceptable internal consistency and is more specific to
colposcopy practice, using this questionnaire is justified to assess for patient satisfaction.
In prior studies, various questionnaires and interviews were developed to assess
patient knowledge of colposcopy and cervical dysplasia. One study asked “What is your
understanding of an abnormal smear result”10 while another used an interview to ask
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participants open-ended questions like “Do you know why you are scheduled for this
appointment?” or “What is a colposcopy?”15 Other studies have used questionnaire formats
that have ranged from true/false31 to multiple choice.13,18 As virtually none of these measures
have been tested for their internal consistency or validity, these methods to measure patient
knowledge provide insufficient evidence to determine whether they actually measure patient
knowledge. One study conducted by Kola et al. utilized a 7-item questionnaire asking
participants about their knowledge of smear tests, symptoms of cervical dysplasia, the
meaning of smear tests, and what a colposcopy is.31 They found that their questionnaire
Cronbach’s alpha was .86. This suggests that this questionnaire may be more reliable. While
the specific details of the questionnaire are unclear, we will design our own true/false
questionnaire based off of the mentioned topics covered in this study. An example of this
knowledge questionnaire can be seen in Appendix E.
To measure pain, prior studies have utilized the visual analog scale (VAS).24,26-29,32
This scale is a self-reported tool that has been used extensively to study pain in various
disciplines and has been well-validated.40 Usually, it is a 10 cm line labeled with “no pain”
on one end and “the worst pain I have ever felt” on the other end. Participants will then mark
on the line the corresponding intensity of pain they felt. Reliability of the VAS for acute pain
has also been found to be high with an intra-class correlation coefficient ranging from .97.99 in patients with acute pain in the Emergency Department.41,42 Moreover, it is applicable
across a wide variety of populations and easy to administer. However, the VAS does have its
limitations which include a ceiling effect and the inability to describe the quality of pain. In
our proposed study, we are interested in the severity of pain and as such, these limitations are
permissible.
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Confounders
Previous studies indicate potential confounders consist of the following: age, smoking
behavior, history of anxiety or depression, prior colposcopy, having multiple providers
perform the colposcopy due to differences in patient interaction style, referring cytology
severity, prior medical knowledge, parity, marital status, age, body mass index (BMI),
educational level, waiting time, and procedure time. 3,25,29,30,32 Some of these confounders
were selected based on the hypothesis that they (age, parity, and educational level) may be
inversely related with anxiety as these patients may have more experience with medical
exams and will therefore be more relaxed.32 For BMI, it is hypothesized that those with a
higher BMI may feel more ashamed during medical exams, thus influencing their anxiety
levels during colposcopy.32 Higher BMI may also make the exam more difficult, increasing
the procedure time and in effect increasing anxiety levels. Other variables have been
demonstrated to have an independent effect on anxiety. In the study conducted by Hilal et al.,
on multiple linear regression analysis, they found that study center (P=.028), smoking
behavior (P=.025) and BMI (P= .033) had a significant effect on mean reduction of anxiety
scores. 32 Another study examining predictors of pre-procedural anxiety found women who
were single and women who had children independently predicted higher pre-colposcopy
state anxiety (p<0.05).3 The authors hypothesize that this may be due to a potential protective
effect from having a partner in the case of being married and from fertility or family related
concerns in the case of having children.3 Finally, longer waiting times and longer procedures
have been suggested in the literature as possible confounders as they may negatively
influence anxiety although to date, no empirical studies have yet demonstrated this with data.
6,19,26,27,30,43
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Some studies also chose to record whether a biopsy or endocervical curettage (ECC)
was performed during the exam as well as the mean number of biopsies taken.24,26,29 In all
three of the studies that recorded this data, none of these procedures were planned
beforehand and patients were alerted to whether any of these procedures would be performed
right before they were done. Chan et al. did not find that the performance of a biopsy during
the procedure independently affected the anxiety levels of the participants while the other
studies did not adjust for this variable in their data analysis. While the data so far has not
demonstrated that the performance of a biopsy or ECC affects anxiety levels, it can be
reasonably hypothesized that having these procedures performed during the colposcopic
exam may influence anxiety levels as they may increase participants’ worries about cancer.
Consequently, it is reasonable to suggest that the performance of a biopsy or ECC during the
exam may act as a potential confounder.
These potential confounders can ultimately be limited through appropriate exclusion
criteria; the use of one clinician performing the colposcopic exam; recording baseline patient
characteristics, waiting time and procedure time, and whether a biopsy or ECC was
performed and how many; providing patients with an informational pamphlet concerning
colposcopy and how to prepare for it; and through multivariate data analysis.
Selection Criteria
Most studies reviewed have included patients who were age >18, had the ability to
read, write, or communicate in the native language of the country, and who had been referred
for first time colposcopy.10,26,29,31,32 The age criterion is based on data from previous studies
that have found that cervical dysplasia is rarely found in women under the age of 20 and the
average age of diagnosis of cervical cancer is 53, globally.1,44 It is logical to limit the age of
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participants to those >21 as this criterion will capture the target population, exclude
adolescents who are not recommended to receive the Pap test, and simplify the protocol. The
second criterion is another reasonable inclusion criterion as the intervention and the measures
of anxiety all require the ability to communicate. In our proposed study, it will be reasonable
to include English-speaking and Spanish-speaking patients to more fully capture our target
population. Finally, the third criterion is justified as it has been hypothesized that previous
experience with colposcopy may influence the anxiety levels of subsequent colposcopies.
Patients excluded in most of the reviewed studies included those who were blind, had
a prior colposcopy, had mental impairments, or were currently pregnant. These exclusion
criteria were chosen in consideration of practicalities of the intervention and to eliminate
potential confounders.15,18,24,27,32 Some prior studies have also chosen to exclude patients who
have had a history of anxiety or depression but we will include these patients in our proposed
study as we anticipate many of the people from our target population will have these
disorders.29,32 Moreover, we believe that including this patient population may help to guide
care in decreasing anxiety in patients who need it the most.
Sampling Techniques
Virtually all reviewed studies have utilized consecutive sampling to achieve their
sample size.10,13,15,16,18-21,23,24,26-29,31,32 Consecutive sampling is a kind of nonprobability
sampling technique, meaning that not every individual in the population has an equal
likelihood of being selected for the study. However, due to the practical restraints of
recruiting enough eligible patients, this will be an acceptable technique to recruit patients in
our proposed study.
Intervention
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Previous studies have utilized some model of video colposcope to allow the patients
to view their own colposcopy exam as an intervention. One study reported that viewing the
monitor was encouraged but the participants were not forced to do so.23 Another study asked
their participants to focused on the sensations they were feeling during the video
colposcopy.31 Most studies had more than one clinician performing the colposcopies with the
exception of one study. Increased efficiency in the clinic is one advantage of having several
clinicians perform colposcopies. However, having more than one clinician perform the
colposcopy introduces the possible confounder of clinician style of interaction with patients.
To limit confounders, it is justified in our study to limit all colposcopies to one clinician.
2.6 CONCLUSION
The existing literature on the efficacy of video colposcopy to decrease anxiety in first
time colposcopy patients remains both scarce and inconclusive. Half of the randomized
controlled trials suggest a potential benefit while the other half do not support this
conclusion. Study design problems limit the interpretation of these results and provide
insufficient evidence to either support or refute their conclusions. Moreover, limited
generalizability due to the inadequate reporting of certain patient demographics of these
studies leaves a gap in the literature about the effect of video colposcopy in low income
patients who are disproportionately affected by this problem. As a simple interactive and
educational tool that does not incur any known additional risks with colposcopy, video
colposcopy represents a promising tool for further evaluation in patients presenting for first
time colposcopy. A well designed prospective single blind randomized controlled trial will
provide more robust data and help to bridge this gap as it will be the first study that will
examine the effects of video colposcopy in reducing anxiety in a low-income racially diverse
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patient population. Mean reduction of anxiety measured through the difference of precolposcopy STAI scores from post-colposcopy STAI scores will provide meaningful results
on the effect of video colposcopy on anxiety while patient adherence to follow-up, patient
knowledge of colposcopy and cervical dysplasia, patient satisfaction, and patient pain during
the procedure as secondary outcomes will provide meaningful data on other potential benefits
of video colposcopy.
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Chapter 3: Study Methods
3.1- STUDY DESIGN
We will conduct a prospective single blind randomized controlled trial in low-income
women referred to the Yale New Haven Hospital Women’s Center for first time colposcopy.
Patients will be randomized to the intervention group or the control group using a computerized
randomization tool. To implement a single blind design, we will inform patients that we are
conducting a study on anxiety but will not inform them about the role of video colposcopy until
the colposcopic exam is over. This will decrease performance bias. Due to the nature of the
intervention, the clinician performing the colposcopy will not be blinded. Data analysts will be
blinded to further decrease bias.
3.2-STUDY POPULATION AND SAMPLING
Our study population will include women presenting to Yale New Haven Hospital’s
Women’s Center (a U.S. safety net clinic serving a racially and ethnically diverse population of
low-income women) for first cervical colposcopy. All patients who satisfy the inclusion and
exclusion criteria will be eligible for the study and will be approached to participate in the study.
We will use consecutive sampling to recruit patients until we have satisfied our calculated
sample size of 286 patients total with 143 patients in each arm.
Inclusion Criteria
Our inclusion criteria will include the following: ability to read, write or communicate in
English or Spanish, age >21, Medicaid or uninsured insurance status, and referral for first time
colposcopy. English and Spanish speakers will be included in this study as these are the most
predominantly spoken languages in New Haven, CT. Those falling outside of these languages
will be excluded to simplify the protocol but ensure that most of the population presenting to the
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Women’s Center are able to participate in the study. Women over the age of 21 will be included
to further simplify the protocol and exclude adolescents. Medicaid or uninsured insurance status
will serve as a proxy for low-income individuals.
Exclusion Criteria
Our exclusion criteria will include the following: presence of a language barrier, mental
impairment, inability to provide informed consent, blindness, prior colposcopy, or current
pregnancy. These exclusion criteria will be used due to the practical limitations of the
intervention and to decrease the number of potential confounders.
3.3-SUBJECT PROTECTION AND CONFIDENTIALITY
We will obtain Institutional Review Board (IRB) approval as dictated by the Yale IRB
Policy 100 PR.1 Review by a Convened Institutional Review Board. For every eligible
participant, we will require written, informed consent. As outlined in the Yale IRB policy 200
Informed Consent for Human Research form, informed consent will be conducted in a clear and
understandable manner to the participant. The consent form will outline the purpose of the study,
the duration of participation, description of the procedures, and possible risks or discomforts.
Possible benefits that can be reasonably expected as a result from the research will be relayed to
the patient as well as any disclosures of any appropriate alternative procedures, if any, that may
be beneficial to the participants. The consent form will further include confidentiality practices,
investigator contact information should any questions or concerns arise, and a statement that
research participation is completely voluntary and that the participant may discontinue
participation at any time with no penalty. A signed copy will be given to the participant for
personal records. An example consent form is shown in Appendix A.
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All staff members involved in the study will be required to successfully complete Health
Insurance Portability and Accountability Act (HIPAA) training prior to the start of the study and
carry out study protocols in accordance with HIPAA regulations. The research assistant will
explain to participants their HIPAA rights and participants will also receive a brochure
containing detailed information about HIPAA prior to signing the informed consent form.
The medical information collected throughout the duration of the study will be stored on
a secure server with data encryption software. Access to this information will be restricted to the
research team members directly involved in the study and will be password protected. Participant
identifiers like name, date of birth, and medical record number will be replaced as soon as
possible by a random computer-generated identification number to maintain participant privacy.
3.4-RECRUITMENT
Patients referred to the Yale New Haven Hospital’s Women’s Center will be screened to
participate in the study. Those who fulfill the inclusion and exclusion criteria will be eligible for
the study. The research assistant will approach study participants during the initial consultation
and inform them of the medical implications of the study. They will be informed that
participating in the study is completely voluntary and that if they do decide to participate,
informed consent will need to be obtained. Participants will not be compensated for participation
in this study.
3.5-STUDY VARIABLES AND MEASURES
We will utilize video colposcopy as the intervention and the model of video colposcope
we will use will be the Cooper Surgical Leisegang Optik Model 2 video colposcope. This model
is a photo swing colposcope with a Canon EOS Rebel Camera that has high quality German
optics. During the colposcopy, patients will be able to view a television monitor that transmits a
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real time feed of the exam and participants will be encouraged to participate in their own care.
Colposcopic findings will be discussed with the participant during the exam. The control will be
a traditional non-video colposcopy. The patient will be unable to view her colposcopy if assigned
the control group and colposcopy findings will be discussed with the participant after the exam
has concluded. The primary outcome variable will be the reduction of anxiety as measured by the
difference of pre-colposcopy and post-colposcopy STAI. An example of the STAI questionnaire
we will use is shown in Appendix C. Secondary outcome variables will include patient
adherence to follow-up, patient satisfaction, patient knowledge of colposcopy and cervical
dysplasia, and patient pain during the procedure. Adherence to follow-up will be measured by
whether or not the patient returns for the follow-up appointment or reschedules the original
appointment. Patient satisfaction will be measured by the Patient’s Experience and Attitude
Colposcopy Eindhoven Questionnaire (PEACE-q). An example of this questionnaire can be seen
in Appendix D. Patient knowledge of colposcopy and cervical dysplasia will be measured by a
post-colposcopy true/false questionnaire. A correct answer will equal 1 point while an incorrect
answer will equal 0 points. A higher total score will correspond with better knowledge about
cervical dysplasia and colposcopy. An example of this questionnaire can be seen in Appendix E.
Patient pain during the procedure will be measure with the VAS. An example of the VAS we
will use is shown in Appendix F.
3.6-METHODOLOGY CONSIDERATIONS
Blinding
The participants will be blinded to the intervention. We will ask eligible patients to
participate in a study about reducing anxiety but we will not inform the patients about the role of
video colposcopy until after the exam. Due to the nature of the study, the colposcopist will not be
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blinded. Outcome assessors and data analysts will be blinded to which group participants were
randomized, in order to decrease information bias.
Assignment of Intervention
Patients will be assigned to treatment or control groups through a computerized
randomization tool by a nurse not directly involved with the study. These allocation lists will
then be placed into opaque envelopes to be opened right before the colposcopy. Participants will
be allocated in a 1:1 ratio.
Monitoring of Adverse Events
At follow-up, study participants will be asked if they had experienced any complications
as a result of the colposcopy including: bleeding, abdominal or pelvic pain, vaginal discharge, or
signs of infection like fever. Should any of these patients experience any concerning symptoms
in the days following colposcopy, they will be informed to call the clinic and be evaluated. If a
patient fails to show up for their follow-up appointment, patients will be called over the phone to
reschedule their original appointment and asked about any of these complications.
Data Collection
The women who agree to participate in the study and give informed consent will fill out
either the English or the Spanish version of the STAI questionnaire as well as baseline patient
demographics prior to the colposcopic exam. Immediately after the colposcopy, patients will fill
out another questionnaire containing only the state version of the STAI, the true/false patient
questionnaire, PEACE-q questionnaire, and the VAS. Data on participant adherence to follow-up
will be collected as follows: those who attend their follow-up appointment or reschedule will be
recorded as adherent while whose fail to do either of those will be considered non-adherent.
Sample Size Calculation
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Our sample size calculation is based on data from Danhauer et al. who has a similar
patient population to our target population and Chan et al. who found music to decrease anxiety
in first time colposcopy patients.1,2 In the study by Danhauer et al., the mean change in STAI
with traditional colposcopy was 2.6. In the study conducted in 2003 by Chan et al. a mean
change in STAI of 7.11(SD of 12.84) was found in the music group. Assuming that this
intervention will have a similar or non-inferior effect, 7.11-2.6=4.5 which will be the estimated
effect size. Thus, a sample size of 256 will be required to detect an effect size of 4.5 with an  of
5% and a power of 80%. Assuming a 10% drop out rate and to ensure an even number of
participants in each arm, a conservative sample size of 286 will be required with 143 in each
arm. The sample size calculation is included in Appendix B.
Data Analysis
Descriptive statistics will include age, BMI, smoking behavior, race/ethnicity, SES
bracket, educational level, parity, marital status, referring cytology, and current concomitant
disease. They will be reported as means and standard deviation for parametric data or as medians
and interquartile range for non-parametric data. Categorical data will be reported as relative
frequencies. The primary outcome will be mean reduction in STAI and will be reported as means
and standard deviation. Correspondingly, we will use a t test for the statistical analysis. The
secondary outcomes will be adherence to follow-up, patient satisfaction, patient knowledge, and
pain during the procedure. Patient adherence to follow-up will be reported as proportions. We
will use the Chi Square test for statistical analysis. Patient satisfaction will be measured with the
PEACE-q and will be reported as means and standard deviation. Accordingly, we will use the t
test for statistical analysis. Patient knowledge will be assessed using a true/false questionnaire. A
correct answer will earn 1 point while an incorrect answer will earn 0 points. The sum will be
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reported as means and standard deviation. Correspondingly, we will utilize a t test for statistical
analysis. Finally, we will measure pain during the procedure using VAS and it will be reported as
means and standard deviation. For statistical analysis we will use the t test for statistical analysis.
A significance of P < 0.05 will be considered achieving statistical significance and all statistical
tests will be two-tailed. Analysis will be done under the intention to treat principle. To account
for the effect of potential confounders, multiple linear regression will be performed with the
reduction in STAI scores as the dependent variable and study group, age, BMI, smoking
behavior, race, SES, marital status, waiting time, procedure time, performance of a biopsy or
ECC, and level of education as independent variables. Baseline characteristics of all participants
will be obtained at the initial consultation. An example of these characteristics can be seen below
in Table 1.
Table 1: Participant Baseline Characteristics

Age (years)
Income (USD)
<$20,000
>$20,000
Marital Status
Single
Divorced
Widowed
Married
Cohabitated
Highest level of education achieved
None
High School
Associate’s Degree
Bachelor’s Degree
Master’s Degree
PhD
Race
White
Hispanic

Video Colposcopy
N=143
Mean SD

Control
N=143
Mean SD

(n)%
(n)%

(n)%
(n)%

(n)%
(n)%
(n)%
(n)%
(n)%

(n)%
(n)%
(n)%
(n)%
(n)%

P-Value
T test
Chi square

Chi square

Chi square
(n)%
(n)%
(n)%
(n)%
(n)%
(n)%

(n)%
(n)%
(n)%
(n)%
(n)%
(n)%

(n)%
(n)%

(n)%
(n)%

Chi square
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Asian
Black
Other
Referring Pap test
ASCUS
AGC
LSIL
HSIL
Other
Parity
Nulliparity
Primiparity
Multiparity
Body Mass Index (kg/m2)

(n)%
(n)%
(n)%

(n)%
(n)%
(n)%

(n)%
(n)%
(n)%
(n)%
(n)%

(n)%
(n)%
(n)%
(n)%
(n)%

(n)%
(n)%
(n)%
Median/ IQ range

Waiting time in waiting room
(minutes)
Colposcopy procedure time
(minutes)
Current smoker
History of anxiety or depression
Current use of any SSRIs or
benzodiazepines
Current concomitant disease
(yes/no)*
Colposcopic impression
Normal
CIN 1
CIN 2/3
Suspicious for invasion
Nonspecific
Performance of procedure
Biopsy (yes/no)
ECC (yes/no)
No
Number of biopsies taken

Mean SD

(n)%
(n)%
(n)%
Median/ IQ
range
Mean SD

Mean SD

Mean SD

T-test

(n)%
(n)%
(n)%

(n)%
(n)%
(n)%

Chi square
Chi square
Chi square

(n)%

(n)%

Chi square

(n)%
(n)%
(n)%
(n)%
(n)%

(n)%
(n)%
(n)%
(n)%
(n)%

(n)%
(n)%
(n)%
Mean SD

(n)%
(n)%
(n)%
Mean SD

Chi square

Chi square

Whitney U
T-test

Chi square

Chi square

T-test

*Current concomitant disease will be recorded via patient self-report and will constitute an answer of yes if patient
is currently being evaluated or treated for any medical conditions

3.6- TIMELINE AND RESOURCES
Our study will be performed over a two-year time period. This time frame includes
recruitment, data collection, and statistical analysis. Currently, the Yale New Haven Hospital
Women’s Center schedules about twenty colposcopies or loop electrosurgery excision surgeries
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(LEEPs) every week. Based on this data and our consecutive sampling method, we will
conservatively estimate that it will take approximately 6 months to recruit the necessary number
of eligible patients accounting for both patients who choose not to participate in the study and a
10% dropout rate. Data collection will occur simultaneously and follow-up will take up to a
maximum of one year. We expect data analysis to take 1-3 months.
Our study will require one principle investigator, one co-principle investigator, one
gynecologist trained in colposcopy, one colposcopy clinic nurse, and one Spanish speaking
research assistant. The research assistant will help with recruitment and serve as a resource for
participants to ask any questions should they have any when approached for the study. The
colposcopy nurse will help carry out the protocols and oversee patients while they are filling out
their questionnaires. The gynecologist trained in colposcopy will perform all colposcopies
regardless of which group participants were randomized, in order to limit the confounding effects
of having multiple providers perform the colposcopic exam. The principle investigator and coprinciple investigator will oversee the study as a whole to ensure protocols are being carried out
appropriately. The co-principle investigator and research assistant will perform the data analysis.
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Chapter 4: Conclusion
4.1 -ADVANTAGES AND DISADVANTAGES
This proposed study serves to synthesize existing literature to provide more robust
evidence on the efficacy of video colposcopy to reduce anxiety in a patient population that has
yet to be studied. One key advantage of this study over previous studies is the utilization of
design protocols intended to minimize bias. Previous studies on video colposcopy have been
unblinded due to the nature of the intervention. 1-4 Our study has the advantage of a single blind
design to decrease performance and ascertainment bias. Next, the use of a single provider to
perform the colposcopy and adjusting for several important confounders in the data analysis
increases the likelihood that we are assessing the true relationship between video colposcopy and
anxiety. As a result, these design elements will produce more robust and accurate results. Our
secondary outcome of patient adherence to follow-up may also provide more evidence in the
existing literature about improving patient adherence with a larger sample size.5 Finally, a major
advantage our study has compared to the existing literature is the new data that will be obtained
regarding anxiety reduction with video colposcopy in low-income patients. Overall, the proposed
study will provide more compelling evidence on the efficacy of video colposcopy to decrease
anxiety, in a population previously unstudied.
Disadvantages of our study include not being able to blind the gynecologist performing
the colposcopies, the limited external validity of the study, and the use of a self-reported measure
of anxiety. While we will be blinding participants to the intervention, we will be unable to blind
the gynecologist who will perform the colposcopies due to the nature of the intervention. This
introduces a source of performance and ascertainment bias. Studying low-income patients also
limits our external validity. Nevertheless, as there is currently no data evaluating video
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colposcopy’s effect on anxiety in this population and considering that they are the most
negatively affected by cervical cancer, the results of this study will contribute important and
meaningful data to the existing literature. Finally, as we have chosen to use STAI as our measure
of anxiety and it is a self-reported index of anxiety, we will only have subjective data and no
objective measure of anxiety. However, as STAI has been the gold standard to measure anxiety
across various disciplines, we believe that this limitation is acceptable.
4.2-CLINICAL AND/OR PUBLIC HEALTH SIGNIFICANCE
Routine cervical cancer screening is the pillar of prevention that has helped decrease the
incidence and prevalence rate of cervical cancer in the U.S. since the 1950’s. However, recent
data indicates that these trends are stagnating indicating the need for improvements in
management and screening.6 Studies examining predictors of poor screening indicate that anxiety
is a significant barrier.7,8 A wealth of studies examining interventions to decrease this barrier
exist in the current literature but no single intervention has demonstrated consistent results. A
few previous studies have explored the effect of using video colposcopy to reduce anxiety in first
time colposcopy patients but these studies have design shortcomings and have produced mixed
results. Furthermore, the results of current literature remain limited to certain populations. The
lack of reporting of certain demographic data from previous studies leaves the effect of video
colposcopy on anxiety in low income patients unknown and an area of significant interest.
Results from this study will provide novel and quality data on whether video colposcopy
has any utility in decreasing anxiety in low-income patients. This may in turn establish video
colposcopy as a simple and easily employed tool for colposcopy clinics to decrease anxiety to
improve cervical cancer screening. If this study finds a negative result, the results will still
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provide meaningful data to guide future directions in finding a useful intervention to decrease
anxiety in low-income women presenting for first time colposcopy.
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Appendix A: Consent Forms
CONSENT FOR PARTICIPATION IN A RESEARCH PROJECT
YALE UNIVERSITY SCHOOL OF MEDICINE – YALE-NEW HAVEN HOSPITAL
WOMEN’S CENTER
Study Title: VIDEO COLPOSCOPY FOR DECREASING ANXIETY IN A LOW-INCOME
SETTING
Principal Investigator: Sangini Sheth, MD, MPH
Co-Principal Investigator: Jessica Zheng, PA-SII
Funding Source: Yale University School of Medicine Physician Associate Program
Invitation to Participate and Description of Project:
You are invited to participate in a research study about interventions to reduce anxiety in
first time colposcopy patients. You have been asked to participate because you are over the age
of 21 and have been referred for colposcopy for the first time following an abnormal Pap test
result. Approximately 286 patients will participate in this study.
In order to decide whether or not you wish to be a part of this research study you should
know enough about its risks and benefits to make an informed decision. This consent form gives
you detailed information about the research study, which a member of the research team will
discuss with you. This discussion should go over all aspects of this research: its purpose, the
procedures that will be performed, any risks of the procedures, possible benefits and possible
alternative treatments. Once you understand the study, you will be asked if you wish to
participate; if so, you will be asked to sign this form. You will receive a copy of this signed form
for your records.
Description of Procedures:
➢ If you decide to participate in this study, you will be randomly assigned to one of two
groups. The first group will undergo colposcopy with the intervention and the second
group will undergo a traditional colposcopy. Randomization will be achieved with a
random computer-generated sequence.
➢ Prior to undergoing your colposcopy, you will be asked to fill out some demographic
information as well as some questionnaires regarding your level of anxiety. We ask that
you complete these questionnaires to the best of your ability.
➢ Following your colposcopy, you will be asked to complete a couple of questionnaires
about anxiety, pain, your knowledge of cervical cancer/colposcopy, and your overall
colposcopy experience.
➢ Depending on which group you have been randomized to, the provider performing the
colposcopy will inform you of the findings during the exam or after. The same provider
will perform all colposcopies in the study.
➢ After the colposcopy, you will be asked to set up a follow-up appointment to monitor for
any changes. Once you have attended your follow-up appointment, that will mark the
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end of your enrollment of this study. We anticipate the total enrollment time of this study
to be a maximum length of 12 months but depending on your findings, the enrollment
time may be shorter.
➢ You will be alerted of any important or significant findings that are discovered during the
course of your participation in this study that may affect your willingness to continue
your participation. If we find that one method offers better outcomes than the other, we
will conclude the study and offer the better method to all of our participants.
➢ You may voluntarily withdraw from this study at any time.
➢ A description of this clinical trial will be available on http://www.Clinicaltrials.gov as
required by U.S. Law. This website will not include any information that will personally
identify you. The purpose of this database is to allow everyone to see what research has
been done and what research is currently being done. At most, the website will include
summary of the results. You can search this website at any time. If research results are
published, your personal information will not be given.
Risks and/or Inconveniences:
➢ Colposcopy can be an uncomfortable and anxiety provoking procedure for many patients.
We will do our best to maintain an environment that is as comfortable as possible within
our means.
➢ The risks of colposcopy include some pain or discomfort during and after the procedure.
A previous study found that around 14-18% of women experienced one of these symptoms
after colposcopy. Extremely rare complications of colposcopy include severe abdominal
or pelvic pain, heavy bleeding lasting longer than two weeks, purulent vaginal discharge,
fever or chills, and infection. Should any of these symptoms arise following the procedure,
you should contact the clinic to be evaluated and treated. Colposcopy will not make it more
difficult to become pregnant.
➢ Biopsies or endocervical curettage may need to be performed during the colposcopy
depending on the colposcopy findings. Rare complications of these procedures include
bleeding or infection of the site. Should there be any significant bleeding we will apply
ferric subsulfate (Monsel’s solution) with a cotton swab to the area. Signs of infection may
present as pelvic pain, purulent vaginal discharge, or abnormal bleeding or clotting. If any
of these signs or symptoms are present after the procedure, you should contact the clinic to
be evaluated and treated for possible infection.
➢ The intervention being studied has reported no additional major risks or side effects
compared to standard traditional colposcopy.
Benefits
➢ This research may provide more conclusive evidence on methods to decrease anxiety in
low income patient populations presenting for first time colposcopy.
➢ This study may improve current colposcopy practice and potentially increase cervical
cancer screening rates.
➢ We expect this study to directly benefit low income populations and indirectly benefit other
populations of patients undergoing colposcopy.
Economic Considerations
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There will be no compensation for participation in this study and no costs will be associated with
your participation in the study. Parking will be provided free of charge.
Treatment Alternatives
If you choose not to participate in this study, you may proceed with a traditional colposcopy. Other
strategies used to decrease anxiety in first time colposcopy patients include informational
pamphlets, video information, counselling sessions, guided imagery, targeted information, and
music. You will be given an informational pamphlet at the initial consultation but other strategies
will not be used in this study.
Confidentiality
Any identifiable information that is obtained in connection with this study will remain
confidential and will be disclosed only with your permission or as required by U.S. or State law.
Examples of information that we are legally required to disclose include abuse of a child or
elderly person, or certain reportable diseases. Information will be kept confidential by replacing
personal identifiers with identification numbers on study forms, storing signed forms in locked
cabinets, and storing collected data on a password protected, HIPAA compliant, encrypted
server. When the results of the research are published or discussed in conferences, no
information will be included that would reveal your identity unless your specific permission is
obtained.
We understand that information about your health is personal, and we are committed to
protecting the privacy of that information. If you decide to be in this study, the researcher will
collect information that identifies you personally. This may include your name and address,
telephone number, and email address, or mobile phone number. This information will be deidentified at the earliest reasonable time after we receive it, meaning we will replace your
identifying information with a code that does not directly identify you. The data will be kept in
this form until 2 weeks after acquisition of all study data, at which the personal information will
be destroyed and the data will become anonymous. The data will remain in this anonymous form
indefinitely.
The information about your health that will be collected in this study includes:
•
•
•

Records about past medical history
Records about phone calls made as part of this research study
Records about your study visits

Information about you and your health that might identify you may be used by or given to:
•

Representatives from Yale University, the Yale Human Research Protection Program and
the Yale Human Investigation Committee (the committee that reviews, approves, and
monitors research on human subjects), who are responsible for ensuring research
compliance. These individuals are required to keep all information confidential.
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•
•
•
•

Those individuals at Yale who are responsible for the financial oversight of research
including billings and payments
The Principal Investigator (Dr. Sangini Sheth)
Co-Investigators and other investigators
Study Coordinator and Members of the research team

By signing this form, you authorize the use and/or disclosure of the information described above
for this research study. The purpose for the uses and disclosures you are authorizing is to ensure
that the information relating to this research is available to all parties who may need it for
research purposes.
All health care providers subject to HIPAA (Health Insurance Portability and Accountability
Act) are required to protect the privacy of your information. The research staff at the Yale
School of Medicine are required to comply with HIPAA and to ensure the confidentiality of your
child’s information.
If you choose to participate in this study, the investigators will check your electronic medical
record at Yale (EPIC) to make sure you qualify. Any access to your electronic medical record
will be done consistent with HIPAA regulations.
Some of the individuals or agencies listed above may not be subject to HIPAA and therefore may
not be required to provide the same type of confidentiality protection. They could use or disclose
your information in ways not mentioned in this form. However, to better protect your health
information, agreements are in place with these individuals and/or companies that require that
they keep your information confidential.
You have the right to review and copy your health information in your medical record in
accordance with institutional medical records policies. This authorization to use and disclose
your health information collected during your participation in this study will never expire.
In Case of Injury
If you are injured while participating in the study, seek treatment and contact the study doctor as
soon as you are able.
Yale School of Medicine and Yale-New Haven Hospital do not provide funds for the treatment of
research-related injury. If you are injured as a result of your participation in this study, treatment
will be provided. No additional financial compensation for injury or lost wages is available. You
do no give up any of your legal rights by signing this form.
Voluntary Participation and Withdrawal
Subjects have the right to withdraw their data once it has been collected. However, this will only
be possible before it has been deidentified. Once data has been collected and deidentified, subjects
will not be able to withdraw their data.
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Refusing to participate will involve no penalty or loss of benefits to which you are otherwise
entitled (such as your health care outside the study, the payment for your health care, and your
health care benefits). However, you will not be able to enroll in this research study or receive study
procedures as a study participant if you do now allow us to use your information as part of this
study. You do not give up any of your legal rights by signing this form.
Withdrawing from the Study
If you do not become a subject, you are free to stop and withdraw from this study at any time
during its course. To withdraw from the study, you can call a member of the research team at any
time and tell them that you no longer want to take part. This will cancel any future appointments.
Withdrawing from the study will involve no penalty or loss of benefits to which you are otherwise
entitled. It will not harm your relationship with your own doctors or with Yale-New Haven
Hospital or Yale University.
When you withdraw from the study, no new health information identifying you will be collected
after that date. Information that has already been gathered may still be used and given to others
until the end of the research study, as necessary to ensure the integrity of the study and/or study
oversight.
Questions
We have used some technical terms in this form. Please feel free to ask about anything you do not
understand and to consider this research and the consent form carefully- as long as you feel
necessary- before you make a decision.
Authorization
I have read (or someone has read to me) this form and have decided to continue to participate in
the project described above. Its general purposes, the particulars of involvement and possible
hazards and inconveniences have been explained to my satisfaction. My signature also indicates
that I have received a copy of this consent form.

Name of Subject:_____________________________

Signature:___________________________________
Date:______________________________________
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___________________________________________
Signature of Principal Investigator

_____________________
Date

or

___________________________________________
Signature of Person Obtaining Consent

___________________
Date

If you have further questions about this project or if you have a research-related problem, you
may contact the Principal Investigator Sangini Sheth MD,MPH at (***)***-**** or the CoPrincipal Investigator Jessica Zheng at (***)***-****. If you would like to talk with someone
other than the researchers to discuss problems, concerns, and questions, offer input, discuss
situations in the event that a member of the research team is not available, or if you have any
questions concerning your rights as a research subject, you may contact the Human Investigation
Committee at (203) 785-4688.
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SHORT FORM WRITTEN CONSENT
FOR SUBJECTS WHO ARE UNABLE TO READ ENGLISH
YALE UNIVERSITY SCHOOL OF MEDICINE – YALE-NEW HAVEN HOSPITAL
WOMEN’S CENTER
Study Title: VIDEO COLPOSCOPY FOR DECREASING ANXIETY IN A LOW-INCOME
SETTING
Principal Investigator: Sangini Sheth, MD, MPH
Co-Principal Investigator: Jessica Zheng, PA-SII
Funding Source: Yale University School of Medicine Physician Associate Program
CONSENT TO PARTICIPATE IN RESEARCH
You are being asked to participate in a research study.
Before you agree, the investigator must tell you about the (i) purposes, procedures, and duration
of the research; (ii) any procedures which are experimental; (iii) any reasonably foreseeable
risks, discomforts, and benefits of the research; (iv) any potentially beneficial alternative
procedures or treatments; and (v) how confidentiality will be maintained.
Where applicable, the investigator must also tell you about (i) any available compensation or
medical treatment if injury occurs; (ii) the possibility of unforeseeable risks; (iii) circumstances
when the investigator may halt your participation; (iv) any added costs to you; (v) what happens
if you decide to stop participating; (vi) when you will be told about new findings which may
affect your willingness to participate; and (vii) how many people will be in the study.
If you agree to participate, you must be given a signed copy of this document and a written
summary of the research.
You may contact either the Principal Investigator Dr. Sangini Sheth at (***)***-**** or the Coprincipal investigator Jessica Zheng at (***)***-**** any time you have any questions about the
research or what to do if you are injured. You may contact the Yale Human Research Protection
Program (HRPP) at (203)785-4688 if you have any questions about your rights as a research
subject.
Your participation in this research is voluntary and you will not be penalized or lose benefits if
you refuse to participate or decide to stop.
Signing this document means that the research study, including the above information, has been
described to you orally, and that you voluntarily agree to participate.

___________________________________________
Signature of Participant/LAR
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_____________________
Date

___________________________________________
Signature of Witness
(This should not be the person obtaining consent)

___________________
Date

Witness/Interpreter
By signing this form, you are indicating that:
• The information in the summary document as well as any additional information
conveyed by the research person obtaining consent was presented to the subject in a
language preferred by and understandable to the subject
• The subject’s questions were interpreted and the response of the person obtaining consent
were presented in a language preferred by and understandable to the subject
• At the conclusion of the consent conference the subject was asked in a language preferred
by and understandable to the subject if s/he understood the information and responded
affirmatively.

___________________________________________
Signature of Witness/ Interpreter
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___________________
Date

SPANISH SHORT FORM WRITTEN CONSENT
FORMULARIO ABREVIADO DE CONSENTIMIENTO ESCRITO
PARA INDIVIDOS QUE NO HABLAN NI LEEN EL INGLÉS
ESCUELA DE MEDICINA DE LA UNIVERSIDAD DE YALE-HOSPITAL YALE-NEW
HAVEN CENTRO DE MUJERES
Nombre del estudio: VIDEO COLPOSCOPIA PARA DISMINUIR LA ANSIEDAD EN UNA
CLÍNICA DE BAJOS INGRESOS
Investigador principal: Sangini Sheth, MD, MPH
Investigadora codirectora: Jessica Zheng, PA-SII
Fuente de financiamiento: Escuela de medicina de la Universidad de Yale Programa de medico
asociado
CONSENTIMIENTO PARA PARTICIPAR EN LA INVESTIGACIÓN
Se le está solicitando su participación en un estudio de investigación.
Antes de aceptar, el investigador debe informarle sobre: (i) los propósitos, los procedimientos, y
la duración del estudio; (ii) todo los procedimiento que seas experimentales; (iii) todos posibles
riesgos, incomodidad o beneficio que se puede prever como resultado del estudio; (iv) cualquier
procedimiento o tratamiento alternativo que tenga potencial de beneficiarle; y (v) cómo se
mantendrá la confidencialidad.
Cuando sea aplicable, el investigador también debe informarle sobre: (i) cualquier compensación
o atención médica disponible en caso de lesion; (ii) la posibilidad de riesgos impredecibles; (iii)
situaciones en las que el investigador pueda cesar su participación; (iv) cualquier costo adicional
para usted; (v) lo que pasa si usted decide interrumpir su participación; (vi) cuándo se le
informará sobre nuevos hallazgos que puedan afectar su deseo en participar; (vii) cuántas
personas participarán en el estudio; y su derecho de revocar (anular) su autorización para el uso o
la divulgación de sus datos de salud confidenciales por parte de los investigadores.
Si usted acepta participar, debe recibir una copia firmada de este documento y un resumen del
estudio por escrito.
Puede comunicarse con La Doctora Sangini Seth al (***)***-**** o con Jessica Zheng al
(***)***-**** a qualquier momento que tenga preguntas sobre el estudio o lo que debe hacer si
se encuentra herido. Puede comunicarse con el Programa de Protección de Investigación
Humana de Yale (HRPP) al (203)785-4688 si tiene preguntas sobre sus derechos como sujeto de
una investigación.
Su participación en esta investigación es voluntaria, y usted no será penalizado ni perderá
beneficios al negar su participación o al optar por interrumpirla.
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Al firmar este documento, usted consenta que el estudio de investigación, incluyendo la
información previa, le ha sido explicado oralmente, y que usted acepta participar
voluntariamente.
___________________________________________
Firma del participante/LAR

_____________________
Fecha

___________________________________________
___________________
Firma del testigo
Fecha
(No debe ser la misma persona obteniendo el consentimiento)

Testigo/ Intérprete
Al firmar este formulario, usted afirma que:
• La información en el Documento Sumario (el formulario abreviado) y toda la
información adicional comunicada por el investigador obteniendo el consentimiento del
sujeto, se presentó al sujeto en su idioma preferido y de manera comprensible.
• Las preguntas del sujeto fueron interpretadas y las respuestas de la persona obteniendo el
consentimiento fueron transmitidas al sujeto en su idioma preferido y de la manera
comprensible.
• Al cierre de la conferencia de consentimiento, se le preguntó al sujeto en su idioma
preferido y de manera comprensible, si había comprendido toda la información y
respondía afirmativamente.

___________________________________________
Firma del testigo/intérprete

67

___________________
Fecha

Appendix B: Sample Size Calculation
The sample size calculation was based on a t-test calculator comparing two independent means
assuming normal distribution with the following study parameters:
•
•
•

Alpha, the probability of a type-I error (finding a difference when a difference does
not exist): 0.05
Beta, the probability of a type-II error (not detecting a difference when one actually
exists: 0.2
Power: 0.8

The following equation was used to calculate the sample size:

Assuming a standard deviation of 12.84 units, the study would require a sample size of 128 for
each group (total sample size of 256) to achieve a power of 80% and a level of significance of
5% (two sided), for detecting a true difference in means between the test and the reference group
of 4.5.
Assuming a 10% drop out rate and to ensure an even number of participants in each arm, a final
conservative sample size of 286 will be required with 143 in each arm.
Reference: Dhand, N. K., & Khatkar, M. S. (2014). Statulator: An online statistical calculator.
Sample Size Calculator for Comparing Two Independent Means. Accessed 15 December 2019 at
http://statulator.com/SampleSize/ss2M.html
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Appendix C: STAI Questionnaire

Name_______________________________________Date______________Age_____________
Directions: A number of statements which people have used to describe themselves are given
below. Read each statement and then circle the appropriate value to the right of the statement to
indicate how you feel right now. There are no right or wrong answers. Do not spend too much
time on any one statement but give the answer which seems to describe your present feelings
best.
Almost Sometimes Often
never

Almost
Always

1. I feel calm.

0

1

2

3

2. I feel secure.

0

1

2

3

3. I am tense.

0

1

2

3

4. I feel strained.

0

1

2

3

5. I feel at ease.

0

1

2

3

6. I feel upset.
7. I am presently worrying over possible
misfortunes.

0
0

1
1

2
2

3
3

8. I feel satisfied.

0

1

2

3

9. I feel frightened.

0

1

2

3

10. I feel comfortable.

0

1

2

3

11. I feel self-confident.

0

1

2

3

12. I feel nervous.

0

1

2

3

13. I am jittery.

0

1

2

3

14. I feel indecisive.

0

1

2

3

15. I am relaxed.

0

1

2

3

16. I am content.

0

1

2

3

17. I am worried.

0

1

2

3

18. I feel confused.

0

1

2

3

19. I feel steady.

0

1

2

3

20. I feel pleasant.

0

1

2

3
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Directions: A number of statements which people have used to describe themselves are given
below. Read each statement and then circle the appropriate value to the right of the statement to
indicate how you generally feel. There are no right or wrong answers. Do not spend too much
time on any one statement but give the answer which seems to describe how you generally feel.
Almost
never

Sometimes

Often

Almost
Always

21. I feel pleasant.
22. I feel nervous and restless.
23. I feel satisfied with myself.
24. I wish I could be as happy as others seem to
be.

0
0
0
0

1
1
1
1

2
2
2
2

3
3
3
3

25. I feel like a failure.
26. I feel rested
27. I am “calm, cool, and collected”
28. I feel that difficulties are piling up so that I
cannot overcome them.

0
0
0
0

1
1
1
1

2
2
2
2

3
3
3
3

29. I worry too much over something that really
does not matter.
30. I am happy.
31. I have disturbing thoughts.
32. I lack self-confidence.
33. I feel secure.
34. I make decision easily.
35. I feel inadequate.
36. I am content.
37. Some unimportant thoughts run through my
mind and bothers me.

0

1

2

3

0
0
0
0
0
0
0
0

1
1
1
1
1
1
1
1

2
2
2
2
2
2
2
2

3
3
3
3
3
3
3
3

38. I take disappointments so keenly that I can’t
put them out of my mind.
39. I am a steady person.
40. I get in a state of tension or turmoil as I think
over my recent concerns and interests.

0

1

2

3

0
0

1
1

2
2

3
3

Reference: Spielberger CD, Gorsuch, R. L., Lushene, R., Vagg, P. R., & Jacobs, G. A. Manual
for the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press; 1970.

70

Appendix D: PEACE-q Questionnaire
PATIENT’S EXPERIENCE AND ATTITUDE COLPOSCOPY EINDHOVEN
QUESTIONNAIRE (PEACE-Q)
Directions: A number of statements about your experience with colposcopy are given below.
Read each statement and then circle the appropriate value to the right of the statement to indicate
how strongly you agree or disagree with the statement. There are no right or wrong answers but
give the answer which corresponds best with your experience with colposcopy.

Strongly Agree
agree

Disagree Strongly
disagree

1. I was well-informed about the colposcopy.

1

2

3

4

2. I was preoccupied with the possible
outcome of the colposcopy.
3. I feel stressed about the colposcopy.

1

2

3

4

1

2

3

4

4. I was worried about the outcome of the
colposcopy.

1

2

3

4

5. I was worried about the possible further
treatment options.
6. The gynecologist put me at east.

1

2

3

4

1

2

3

4

7. I am satisfied about the way I received the
results.
8. I was well-informed about the next steps
after the colposcopy.

1

2

3

4

1

2

3

4

Reference: Pop VJM, Wouters T, Bekkers RLM, Spek VRM, Piek JMJ. Development of the
Patient’s Experience and Attitude Colposcopy Eindhoven Questionnaire (PEACE-q). BMC
Health Services Research. 2019;19(1):589.
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Appendix E: True/False Questionnaire
Directions: Below is a true/false questionnaire about colposcopy and cervical dysplasia. Circle
either True or False. Please answer to the best of your ability.
1. True /

False An abnormal Pap test means that I definitely have cancer.

2. True /

False

3. True /

False Cervical dysplasia is another term for cancer.

4. True /

False HPV infection is a risk factor for the development of cervical dysplasia.

5. True /

False A Pap test is a test to detect pre-cancer and cancer.

6. True /

False There are usually no symptoms when a person has cervical dysplasia.

7. True /

False Colposcopy is a procedure used to examine my cervix after an abnormal

If abnormal cells are found during my colposcopy, a biopsy will be done.

Pap test result.
Appendix F: Visual Analog Scale
Directions: Please mark with a vertical line through the horizontal line below to indicate your
response to the question.
Question: How painful was the colposcopy exam?

72

Bibliography
1.

2.

3.
4.

5.

6.
7.

8.

9.

10.

11.

12.

13.

14.

15.

Abdelhakim AM, Samy A, Abbas AM. Effect of music in reducing patient anxiety during
colposcopy: A systematic review and meta-analysis of randomized controlled trials.
Journal of Gynecology Obstetrics and Human Reproduction. 2019;48(10):855-861.
American Cancer Society. Key Statistics for Cervical Cancer.
https://www.cancer.org/cancer/cervical-cancer/about/key-statistics.html. Published 2020.
Accessed March 28, 2020.
Arbyn M, Weiderpass E, Bruni L, et al. Estimates of incidence and mortality of cervical
cancer in 2018: a worldwide analysis. The Lancet Global Health. 2019.
Baker DW, Gazmararian JA, Williams MV, et al. Functional health literacy and the risk
of hospital admission among Medicare managed care enrollees. Am J Public Health.
2002;92(8):1278-1283.
Benard VB, Watson M, Saraiya M, et al. Cervical cancer survival in the United States by
race and stage (2001-2009): Findings from the CONCORD-2 study. Cancer. 2017;123
Suppl 24(Suppl 24):5119-5137.
Bijur PE, Silver W, Gallagher EJ. Reliability of the Visual Analog Scale for
Measurement of Acute Pain. Academic Emergency Medicine. 2001;8(12):1153-1157.
Bosgraaf RP, de Jager WC, Servaes P, Prins JB, Massuger LF, Bekkers RL. Qualitative
insights into the psychological stress before and during colposcopy: a focus group study.
J Psychosom Obstet Gynaecol. 2013;34(4):150-156.
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer
statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA: A Cancer Journal for Clinicians. 2018;68(6):394-424.
Bunevicius A, Staniute M, Brozaitiene J, Pop VJ, Neverauskas J, Bunevicius R.
Screening for anxiety disorders in patients with coronary artery disease. Health Qual Life
Outcomes. 2013;11:37.
Byrom J, Clarke T, Neale J, et al. Can pre-colposcopy sessions reduce anxiety at the time
of colposcopy? A prospective randomised study. Journal of Obstetrics and Gynaecology.
2002;22(4):415-420.
Campion MJ, Brown JR, Mccance DJ, et al. Psychosexual trauma of an abnormal
cervical smear. BJOG: An International Journal of Obstetrics & Gynaecology.
1988;95(2):175-181.
Chan YM, Lee PW, Ng TY, Ngan HY. Could precolposcopy information and counseling
reduce women's anxiety and improve knowledge and compliance to follow-up?
Gynecologic Oncology. 2004;95(2):341-346.
Chan YM, Lee PWH, Ng TY, Ngan HYS, Wong LC. The use of music to reduce anxiety
for patients undergoing colposcopy: a randomized trial. Gynecologic Oncology.
2003;91(1):213-217.
Chantawong N, Charoenkwan K. Effects of Music Listening During Loop Electrosurgical
Excision Procedure on Pain and Anxiety: A Randomized Trial. J Low Genit Tract Dis.
2017;21(4):307-310.
Cutilli CC, Bennett IM. Understanding the health literacy of America: results of the
National Assessment of Adult Literacy. Orthop Nurs. 2009;28(1):27-34.

73

16.

17.

18.

19.

20.

21.

22.

23.

24.

25.

26.

27.

28.

29.

Danhauer SC, Marler B, Rutherford CA, et al. Music or guided imagery for women
undergoing colposcopy: a randomized controlled study of effects on anxiety, perceived
pain, and patient satisfaction. J Low Genit Tract Dis. 2007;11(1):39-45.
de Bie R, Massuger L, Lenselink C, Derksen Y, Prins J, Bekkers R. The role of
individually targeted information to reduce anxiety before colposcopy: a randomised
controlled trial. BJOG: An International Journal of Obstetrics & Gynaecology.
2011;118(8):945-950.
Denny MC, Vahidy F, Vu KYT, Sharrief AZ, Savitz SI. Video-based educational
intervention associated with improved stroke literacy, self-efficacy, and patient
satisfaction. PloS one. 2017;12(3):e0171952.
Doherty IE, Richardson PH, Wolfe CD, Raju KS. The assessment of the psychological
effects of an abnormal cervical smear result and subsequent medical procedures. Journal
of Psychosomatic Obstetrics & Gynecology. 1991;12(4):319-324.
Eggleston KS, Coker AL, Das IP, Cordray ST, Luchok KJ. Understanding Barriers for
Adherence to Follow-Up Care for Abnormal Pap Tests. Journal of Women's Health.
2007;16(3):311-330.
Ferlay J, Colombet M, Soerjomataram I, et al. Estimating the global cancer incidence and
mortality in 2018: GLOBOCAN sources and methods. International Journal of Cancer.
2019;144(8):1941-1953.
Freeman-Wang T, Walker P, Linehan J, Coffey C, Glasser B, Sherr L. Anxiety levels in
women attending colposcopy clinics for treatment for cervical intraepithelial neoplasia: a
randomised trial of written and video information. BJOG: An International Journal of
Obstetrics & Gynaecology. 2001;108(5):482-484.
Galaal K, Bryant A, Deane KH, Al-Khaduri M, Lopes AD. Interventions for reducing
anxiety in women undergoing colposcopy. Cochrane Database Syst Rev.
2011(12):CD006013.
Gallagher EJ, Bijur PE, Latimer C, Silver W. Reliability and validity of a visual analog
scale for acute abdominal pain in the ED. The American Journal of Emergency Medicine.
2002;20(4):287-290.
Gray NM, Sharp L, Cotton SC, et al. Psychological effects of a low-grade abnormal
cervical smear test result: anxiety and associated factors. Br J Cancer. 2006;94(9):12531262.
Greimel ER, Gappmayer-Löcker E, Girardi FL, Huber HP. Increasing women's
knowledge and satisfaction with cervical cancer screening. Journal of Psychosomatic
Obstetrics & Gynecology. 1997;18(4):273-279.
Group USCSW. U.S. Cancer Statistics Data Visualization Tool, based on November
2018 sumission data(1999-2016): U.S. Department of Health and Human Services,
Centers for Disease Control and Prevention and National Cancer Institute.
https://gis.cdc.gov/Cancer/USCS/DataViz.html. Published 2019. Accessed July 10, 2019.
Hilal Z, Alici F, Tempfer CB, Rath K, Nar K, Rezniczek GA. Mozart for Reducing
Patient Anxiety During Colposcopy: A Randomized Controlled Trial. Obstetrics &
Gynecology. 2018;132(4):1047-1055.
Hilal Z, Alici F, Tempfer CB, Seebacher V, Rezniczek GA. Video Colposcopy for
Reducing Patient Anxiety During Colposcopy: A Randomized Controlled Trial.
Obstetrics & Gynecology. 2017;130(2):411-419.
74

30.
31.

32.
33.

34.
35.

36.

37.
38.

39.

40.

41.

42.

43.
44.
45.

46.

Howells REJ, Dunn PDJ, Isasi T, et al. Is the provision of information leaflets before
colposcopy beneficial? A prospective randomised study. 1999;106(6):528-534.
Hui SK, Miller SM, Wen KY, et al. Psychosocial barriers to follow-up adherence after an
abnormal cervical cytology test result among low-income, inner-city women. J Prim Care
Community Health. 2014;5(4):234-241.
James JE, Hardardottir D. Influence of attention focus and trait anxiety on tolerance of
acute pain. British Journal of Health Psychology. 2002;7(2):149-162.
Jeppesen KM, Coyle JD, Miser WF. Screening questions to predict limited health
literacy: a cross-sectional study of patients with diabetes mellitus. Ann Fam Med.
2009;7(1):24-31.
Katz J, Melzack R. MEASUREMENT OF PAIN. Surgical Clinics of North America.
1999;79(2):231-252.
Ketelaars PJW, Buskes MHM, Bosgraaf RP, et al. The effect of video information on
anxiety levels in women attending colposcopy: a randomized controlled trial. Acta
Oncologica. 2017;56(12):1728-1733.
Khanade K, Sasangohar F. Efficacy of Using Heart Rate Measurements as an Indicator to
Monitor Anxiety Disorders: A Scoping Literature Review. Proceedings of the Human
Factors and Ergonomics Society Annual Meeting. 2017;61(1):1783-1787.
Kofler A. Fear and Anxiety Across Continents: The European and the American Way.
Innovation: The European Journal of Social Sciences. 1997;10(4):381-404.
Kola S, Walsh JC. Determinants of pre-procedural state anxiety and negative affect in
first-time colposcopy patients: implications for intervention. European Journal of Cancer
Care. 2012;21(4):469-476.
Kola S, Walsh JC, Hughes BM, Howard S. Matching intra-procedural information with
coping style reduces psychophysiological arousal in women undergoing colposcopy.
Journal of Behavioral Medicine. 2013;36(4):401-412.
Latif S, Ahmed I, Amin MS, Syed I, Ahmed Ne. Exploring the potential impact of health
promotion videos as a low cost intervention to reduce health inequalities: a pilot before
and after study on Bangladeshis in inner-city London. London J Prim Care (Abingdon).
2016;8(4):66-71.
Mak N, Reinders IMA, Slockers SA, Westen EHMN, Maas JWM, Bongers MY. The
effect of music in gynaecological office procedures on pain, anxiety and satisfaction: a
randomized controlled trial. Gynecol Surg. 2017;14(1):14-14.
Marteau TM, Kidd J, Cuddeford L, Walker P. Reducing anxiety in women referred for
colposcopy using an information booklet. British Journal of Health Psychology.
1996;1(2):181-189.
Marteau TM, Walker P, Giles J, Smail M. Anxieties in women undergoing colposcopy.
Br J Obstet Gynaecol. 1990;97(9):859-861.
Nathoo V. Investigation of non-responders at a cervical cancer screening clinic in
Manchester. Br Med J (Clin Res Ed). 1988;296(6628):1041-1042.
Nwankwo C, Corman S, Shah R, Kwon Y. HSR19-102: Direct and Indirect Economic
Burden of Cervical Cancer (CxCa) in the United States in 2015: A Mixed-Methods
Analysis. Journal of the National Comprehensive Cancer Network. 2019;17:HSR19-102.
Percac-Lima S, Aldrich LS, Gamba GB, Bearse AM, Atlas SJ. Barriers to Follow-Up of
an Abnormal Pap Smear in Latina Women Referred for Colposcopy. Journal of General
Internal Medicine. 2010;25(11):1198-1204.
75

47.

48.

49.

50.

51.

52.

53.
54.

55.

56.

57.
58.

59.

60.

61.

Pop VJM, Wouters T, Bekkers RLM, Spek VRM, Piek JMJ. Development of the
Patient’s Experience and Attitude Colposcopy Eindhoven Questionnaire (PEACE-q).
BMC Health Services Research. 2019;19(1):589.
Rickert VI, Kozlowski KJ, Warren AM, Hendon A, Davis P. Adolescents and
colposcopy: The use of different procedures to reduce anxiety. American Journal of
Obstetrics and Gynecology. 1994;170(2):504-508.
Riera A, Ocasio A, Tiyyagura G, et al. A web-based educational video to improve asthma
knowledge for limited English proficiency Latino caregivers. Journal of Asthma.
2017;54(6):624-631.
Rikard RV, Thompson MS, McKinney J, Beauchamp A. Examining health literacy
disparities in the United States: a third look at the National Assessment of Adult Literacy
(NAAL). BMC Public Health. 2016;16(1):975-975.
Rowlands GP, Mehay A, Hampshire S, et al. Characteristics of people with low health
literacy on coronary heart disease GP registers in South London: a cross-sectional study.
BMJ Open. 2013;3(1).
Ryerson AB, Eheman CR, Altekruse SF, et al. Annual Report to the Nation on the Status
of Cancer, 1975-2012, featuring the increasing incidence of liver cancer. Cancer.
2016;122(9):1312-1337.
Safaeian M, Solomon D, Castle PE. Cervical cancer prevention--cervical screening:
science in evolution. Obstet Gynecol Clin North Am. 2007;34(4):739-ix.
Sarkar PK, Miller RJ, Hill L. Counselling at a colposcopy clinic and the emotional wellbeing of women with a positive smear. Journal of Obstetrics and Gynaecology.
1993;13(6):459-461.
Seow A, Wong ML, Smith WCS, Lee HP. Beliefs and Attitudes as Determinants of
Cervical Cancer Screening: A Community-Based Study in Singapore. Preventive
Medicine. 1995;24(2):134-141.
Sharp L, Zurawski J, Roland P, O'Toole C, Hines J. Health literacy, cervical cancer risk
factors, and distress in low-income African-American women seeking colposcopy.
Ethnicity & disease. 2002;12:541-546.
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA: A Cancer Journal for
Clinicians. 2019;69(1):7-34.
Singh GK, Jemal A. Socioeconomic and Racial/Ethnic Disparities in Cancer Mortality,
Incidence, and Survival in the United States, 1950-2014: Over Six Decades of Changing
Patterns and Widening Inequalities. J Environ Public Health. 2017;2017:28193722819372.
Spielberger CD, Gorsuch, R. L., Lushene, R., Vagg, P. R., & Jacobs, G. A. Manual for
the State-Trait Anxiety Inventory. In. Palo Alto, CA: Consulting Psychologists Press;
1970.
Suarez Mora A, Madrigal JM, Jordan L, Patel A. Effectiveness of an Educational
Intervention to Increase Human Papillomavirus Knowledge in High-Risk Minority
Women. Journal of Lower Genital Tract Disease. 2018;22(4):288-294.
Suthasmalee S, Siwadune T. Can Viewing a Video of Colposcopic Examination Improve
Patient Knowledge and Satisfaction with the Procedure? A Prospective Randomized
Controlled Trial. Thai Journal of Obstetrics and Gynaecology. 2015:104-112.

76

62.

63.

64.

65.
66.

67.

68.

69.

70.

Tahseen S, Reid PC. Psychological distress associated with colposcopy: patients'
perception. European Journal of Obstetrics, Gynecology, & Reproductive Biology.
2007;139(1):90-94.
Takacs P, Chakhtoura N, De Santis T. Video colposcopy improves adherence to followup compared to regular colposcopy: a randomized trial. Archives of Gynecology and
Obstetrics. 2004;270(3):182-184.
Tomaino-Brunner C, Freda MC, Damus K, Runowicz CD. Can Precolposcopy Education
Increase Knowledge and Decrease Anxiety? Journal of Obstetric, Gynecologic, &
Neonatal Nursing. 1998;27(6):636-645.
U.S. Preventative Task Force. Screening for Cervical Cancer: US Preventive Services
Task Force Recommendation Statement. JAMA. 2018;320(7):674-686.
Volandes AE, Ariza M, Abbo ED, Paasche-Orlow M. Overcoming educational barriers
for advance care planning in Latinos with video images. J Palliat Med. 2008;11(5):700706.
Vos T, Abajobir AA, Abate KH, et al. Global, regional, and national incidence,
prevalence, and years lived with disability for 328 diseases and injuries for 195 countries,
1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. The
Lancet. 2017;390(10100):1211-1259.
Walsh JC, Curtis R, Mylotte M. Anxiety levels in women attending a colposcopy clinic: a
randomised trial of an educational intervention using video colposcopy. Patient
Education and Counseling. 2004;55(2):247-251.
Wouters T, Soomers J, Smink M, et al. The effect of an animation video on consultation
time, anxiety and satisfaction in women with abnormal cervical cytology: Animation
video reduces colposcopy time. Preventive medicine reports. 2019;13:238-243.
Xie D, Leong FTL. A Cross-Cultural Study of Anxiety Among Chinese and Caucasian
American University Students. Journal of Multicultural Counseling and Development.
2008;36(1):52-63.

77

